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 Growth of an animal results from the interaction of its genetic potential with 
environmental conditions (Bauer et al., 1995). The environment, in regards to fetal 
growth, consists of many variables. This study focuses on in-utero conditions, which 
largely depend on placental transfer (Longtine et al., 2011). Normal placental growth, 
which is an important precursor to adequate placental function, is essential, as the 
placenta is responsible for the transfer of all nutrients, including oxygen, from the mother 
to the fetus (Longtine et al., 2011). Specifically, placental insufficiency results in reduced 
nutrient transfer, increased potential for hypoxic conditions, and increased occurrence of 
intrauterine growth retardation (IUGR) of the fetus (Bell and Ehrhardt, 2002; Gluckman 
and Hanson, 2004; Wallace et al., 2004).  However, if nutrients are not plentiful in 
maternal circulation, or altered concentrations of hormones are present, fetal growth can 
still be hindered (Wu et al., 2006).  
Intrauterine Growth Retardation 
 Intrauterine growth retardation is defined as impaired growth and development of 
the mammalian embryo/fetus or its organs during pregnancy (Wu et al., 2006). According 
to Wu et al (2006), from a statistical standpoint, an organism must weigh at least two 
standard deviations less than the mean to be considered IUGR. It results in smaller 
offspring and negative long-term consequences in the offspring such as insulin resistance, 
Type-2 diabetes, obesity, hypertension, altered organ size, and poor meat quality due to 
an increased ratio of adipose tissue to muscle tissue (Ong et al., 2000; Wu et al., 2006; 
Tosh et al., 2010).  
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In the livestock industry, this results in animals with poor meat quality, with 
increased adipose tissue accretion at the expense of muscle tissue (Boersma and Wit, 
1997). This produces a product that is less healthy, and less palatable, and therefore is 
less in demand by the consumer. Additionally, the cost to raise this animal to slaughter is 
greater, as its feed efficiency, or the amount of feed required for the animal to gain 
muscle, is reduced. There are also implications of IUGR in humans. Metabolic syndrome 
is prevalent, and perhaps maternal diet during gestation is responsible. It is hypothesized 
that these symptoms of metabolic syndrome stem from modifications made to the 
somatotropic axis, the hormonal system responsible for the regulation of growth, and 
modifications to other metabolic pathways, to enhance fetal survival (Thorn et al., 2011).  
The focus of my research was on IUGR as a result of poor maternal nutrition, due 
to both under-feeding and over-feeding of the mother. Sheep were used as a model to 
study concerns to both the livestock industry and to human health. As sheep are 
ruminants, they model the effects to production animals. Before weaning, however, the 
rumen is not fully developed, and the sheep can model effects of a monogastric animal, 
such as humans. 
Vonnahme et al. (2003) used sheep as a model, and determined that nutrient 
restriction of 50% of the nutrient requirements suggested by the National Research 
Council (National Research Council, 1985) for a pregnant ewe from days 28 to 78 of 
gestation results in IUGR of the fetus, as displayed by a 105 g decrease in fetal weight on 
day 78 of development. Over-nutrition of the ewes also imparted negative effects. Over-
nourished ewes had a placenta that was reduced in size by 40%, and in addition, carried 
lambs of low-birth-weight from 128 days of gestation to term (Wallace et al., 1996, 1997, 
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2000). This suggests that the over-nourished, pregnant ewe partitions nutrients toward 
maternal fat deposition, rather than toward placental and fetal development (Wallace et 
al., 2000). 
In this literature review, I will discuss the somatotropic axis, insulin signaling 
pathways, as well as the leptin pathway during normal fetal development and postnatal 
growth. I will also be discussing the role each pathway may have in the phenomenon of 
IUGR, and the specifics of these hypotheses. 
The Somatotropic Axis 
 The somatotropic axis includes hormones secreted from the hypothalamus, the 
anterior pituitary gland, the liver, and other body tissues as well as their receptors; it is 
responsible for the regulation of growth (Renaville et al., 2002). Growth hormone 
releasing hormone (GHRH) is released from the hypothalamus in response to reduced 
circulating concentrations of growth hormone (GH), a 191 amino acid protein hormone 
(Secci and Borromeo, 1997). Growth hormone is secreted in a constant pulsatile manner 
from the anterior pituitary gland (Zinn et al., 1994; Tuggle and Trenkle, 1996). 
Somatostatin (SRIF), on the other hand, is released from the hypothalamus in response to 
an excess of circulating GH; together, these act as a negative feedback loop to maintain 
homeostasis in circulating GH and insulin-like growth factor -1 (IGF-1) concentrations 
(Zinn et al., 1994; Tuggle and Trenkle, 1996). 
 Growth hormone has both direct and indirect effects on body tissues. It directly 
results in triglyceride breakdown, and prevention of lipid accumulation in adipocytes 
(Garten et al., 2012). Its actions are mediated through binding to GH receptors (GHR), 
which bind to cell-surface receptors of the tyrosine kinase JAK2 families, to initiate its 
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numerous cellular functions (Baumann, 1994; Wojcik et al., 1995; Renaville et al., 2002). 
Increased GH concentrations also cause the liver and local tissues to release IGF-1 
(Bloomfield et al., 2006), which acts to directly stimulate growth of target tissues bone 
and muscle, while acting as a negative control of GH (Yakar et al., 1999). Insulin-like 
growth factor-1 also indirectly inhibits GH by stimulation of SRIF secretion (Zinn et al., 
1994; Tuggle and Trenkle, 1996).  
Placental Lactogen 
During gestation, maternal GH is gradually replaced by placental (p)GH (Igout et 
al., 1995). Placental GH is responsible for reducing maternal insulin sensitivity by 45 to 
70%, which serves to prevent normal nutrient partitioning to maintain the fetal nutrient 
supply (Freemark, 2006). This means that insulin resistance is induced by pGH to ensure 
that not all maternal nutrients are transported into cells, but that enough are left in 
circulation to support a growing fetus (Newbern and Freemark, 2011). The increased 
nutrient transfer increases fetal insulin and IGF-1 concentrations, which promote fetal 
growth (Murphy et al., 2006). It does not appear that pGH is regulated by GHRH, but is 
secreted tonically (Baumann, 2009). Mannik et al. (2010) found decreased mRNA 
transcript for pGH associated with infants born small for gestational age (SGA), 
suggested dysregulation of the somatropic axis. Placental GH has not been found in the 
fetal circulation (Newbern and Freemark, 2011).  
IGF-1 
 Insulin-like growth factor-1 is a 70 amino acid protein (Rinderknecht and 
Humbrel, 1978). Growth is stimulated when IGF-1 and IGF-2 bind to the IGF-1 receptor, 
which stimulates bone and muscle development through a tyrosine kinase signaling 
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cascade (Liu et al., 1993). Growth hormone directly stimulates prechondrocyte 
production while IGF-1 is directly responsible for development of new bone (Isaksson et 
al., 1987). Therefore, only IGF-1 and GH together result in normal bone growth. There is 
a similar mechanism of action in muscle accretion; GH stimulates amino acid uptake, the 
precursor to muscle accretion, while IGF-1 is responsible for actual protein synthesis 
(Norrelund, 2005). 
For growth to occur, cooperation between GH and IGF-1 is required. It was found 
that IGF-1-null mice experience 40% reduced growth, whereas IGF-1 receptor-null mice 
experience 55% reduced growth, reduced organ size, reduced muscle development, and 
delayed bone development; they are not viable and die of respiratory failure (Liu et al., 
1993). Inactive GH receptors result in a lack of production of IGF-1, causing Laron 
dwarfism (Laron et al., 1966) whereas overproduction of GH, and therefore IGF-1 is the 
cause of acromegaly (Melmed et al., 1983). The discrepancy in the amount of growth 
reduction means that GH is capable of inducing some growth on its own, but cooperation 
with IGF-1 is required for normal growth. Mice lacking only hepatic IGF-1, however, 
experience normal growth, which confirms the importance of the autrine/paracrine 
actions of local IGF-1 (Yakar et al., 1999).  
 Insulin-like growth factor-1 can also bind to the insulin receptor due to their 
structures being 70% homologous, and can stimulate insulin-like actions (Rinderknecht 
and Humbel, 1978; Zapf et al., 1986). These actions include stimulation of glucose 
transport via translocation of the GLUT4 glucose transporter to the cell surface (Zapf et 
al., 1986). The GLUT4 transporter is responsible for the uptake of glucose from the 
circulation into the cell. IGF-2 can also induce growth through the AKT and MAP-kinase 
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pathway by binding to the insulin receptor (Somwar et al., 2001). Postnatally, GH and 
IGF-1 are the ligands primarily responsible for growth, but IGF-2, which is responsive to 
PGH, rather than fetal GH, is the hormone responsible for fetal development (Gluckman 
and Pinal, 2003). 
 
IGF Binding Proteins (IGFBP) 
 The IGFBP are a family of binding proteins produced by the liver (Govoni et al., 
2005), that bind to IGF and modulate its activity (Breier, 1999). Insulin-like growth 
factor binding proteins -1, -2, -4, and -6 are known to inhibit the actions of IGF-1, and 
restrict growth by binding to IGF to prevent binding to receptors (Govoni et al., 2005). In 
contrast, IGF-3 and -5 are known to stimulate the action of IGF-1, and promote growth 
by binding in a ternary complex with an acid labile subunit (Govoni et al., 2005; Sabin et 
al., 2011). Osteoporosis, or reduced bone mineral density (BMD), is associated with an 
increase in inhibitory proteins, IGFBP-1, -2, -4, and -6, and a decrease in stimulatory 
proteins, IGFBP-3, and -5, as well as IGF-1 (Jehle et al., 2003). 
 The association with IUGR and the IGFBP lies in part, in the availability of IGF. 
The IGFBP have a greater binding affinity for IGF than do the IGF receptors, and only a 
small amount of circulating IGF is unbound and bioactive (Kawai and Rosen, 2012). In 
offspring born to nutrient-restricted or overfed mothers, it is expected that reduced 
growth, would predominate as a response to reduced IGF-1. However, increased 
concentrations of the inhibitory IGFBP would also work to reduce the amount of 
bioactive IGF, resulting in a similar outcome.  
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 Insulin-like growth factor binding protein-3 also has IGF-independent actions. It 
can translocate to the nuclear membrane and bind to retinoid X receptor α (RXRα) and 
peroxisome proliferator-activated receptor γ (PPARγ), both of which modulate adipocyte 
differentiation (Chan et al., 2009). This inhibits the differentiation of adipocytes, 
preventing their maturation (Chan et al., 2009). Insulin-like growth factor binding 
protein-3 reduces insulin-stimulated glucose uptake by reducing glucose uptake by 
GLUT4 transporters, in part by inhibiting GLUT4 transporter translocation (Chan et al., 
2005). Insulin resistance is also induced by a mutant form of IGFBP-3 with an altered 
nuclear localization sequence (NLS), that prevents it from being able to tanslocate to the 
nucleus or bind to RXRα (Chan et al., 2005).  All of this results in insulin resistance and 
impaired glucose when IGFBP-3 is overexpressed (Silha et al., 2002).  
 During fetal development IGFBP-2 is the IGFBP primarily expressed (Shimasaki 
and Ling, 1991). However, postpartum IGFBP-2 concentrations are inversely related to 
body mass index (Mattsson et al., 2008). Therefore, it is inversely correlated with 
adiposity-related insulin resistance, or metabolic syndrome (Heald et al., 2006). 
 Our research focuses on IGFBP-2 and -3 because they have been noted to be 
impacted by both nutrition and stage of development in ruminants (Breier, 1999; Govoni 
et al., 2003). 
Other Affected Metabolic Pathways 
 Other metabolic pathways affected by IUGR include glucose metabolism and 
leptin signaling. This alteration could be due to altered receptor number, altered 
metabolite concentration, or numerous other variables such as mRNA expression and 
epigenetic modifications.  
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The body responds to increased blood glucose concentrations by secreting insulin 
from pancreatic β cells (Yuan et al., 2011). Insulin aids in the facilitated diffusion of 
glucose from the blood into the cells by GLUT transporters; this provides energy for 
cellular respiration and keeps blood glucose concentrations relatively stable (Zapf et al., 
1986). Insulin also works to stimulate glycogenesis, the process by which glucose is 
converted to glycogen, a compound that can be stored in the liver for later energy 
conversion (Zapf et al., 1986). 
 Leptin is a 16kDa protein secreted by adipose tissue and coded for the the ob gene 
(Zhang et al., 1994). Leptin acts on the hypothalamus to suppress appetite, inhibit feed 
intake, and increase energy expenditure (Yura et al., 2005). In ruminants, receptors are 
specifically expressed in the hypothalamus, anterior pituitary gland, and adipose tissue 
(Dyer et al., 1997). In well-fed ewes, there are fewer hypothalamic receptors for leptin 
expressed than in nutrient-restricted ewes (Dyer et al., 1997). It was also determined that 
plasma leptin concentration was positively correlated to body weight, body condition 
score, and adiposity, so it is therefore primarily known as a marker of organism adiposity 
(Delavaud et al., 2000). Thus, increased circulating leptin, either as a function of fewer 
receptors or as a function of leptin resistance is associated with obesity. This holds true 
for humans as well; infants born SGA who experience postnatal compensatory growth 
have greater total body fat, and increased circulating leptin concentrations as adults, than 
infants born at a normal weight (Phillips et al., 1999). 
Nutrition-Induced Changes to Regulation of Growth and Metabolism 
 When a gestating mother is in a period of nutritional stress, IGF-1 concentrations 
decrease, resulting in increased pGH concentrations (Baumann, 2009); this results in 
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nutrient partitioning in favor of the mother, and a fetus with decreased circulating IGF-1 
and reduced growth (Sjogren et al., 1999; Yakar et al., 1999; Tosh et al., 2010). Fetal 
nutrition increases both fetal IGF and fetal insulin, and the concentrations of the two are 
correlated (Baumann, 2009). Fetal pancreatectomy resulted in significantly reduced 
plasma IGF-1, while simultaneously increasing IGF-2 activity (Gluckman et al., 1987). 
Concentrations of GH are increased in response to reduced IGF-1 concentrations, as is 
consistent with a negative feedback loop (Giustina et al., 2008). IGF-1 concentrations are 
also positively correlated with BMD, so when IGF-1 is reduced, BMD should be reduced 
as well (Mohan et al., 2003; Govoni et al., 2005).  
 Over-nutrition of adolescent ewes can also lead to IUGR in their offspring 
(Wallace et al., 1996, 2004). This occurs through nutrient partitioning away from both 
placental and fetal growth, and toward maternal growth, resulting in reduced placental 
and fetal size (Wallace et al., 2004; Lea et al., 2005). Lea et al. (2005) found that on day 
81 of gestation, overnourished adolescent ewes exhibited reduced placental growth, and 
increased level of the pro-apoptotic protein bax, when compared with the control. This 
means that at day 81 of gestation, placental cells from overnourished adolescent ewes are 
not growing as they should be, due to an increased ratio of cells undergoing apoptosis, to 
proliferating cells.  
Hypotheses of the Mechanism of Action 
 Changes to the pregnant mother result in changes in the fetus. There are three 
hypotheses suggesting possible mechanisms behind these fetal changes: the Fetal Insulin 
Hypothesis, the Thrifty Phenotype Hypothesis, and the Predictive Adaptive Response 
Hypothesis. The Fetal Insulin Hypothesis suggests that insulin resistance, glucose 
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intolerance, diabetes, and hypertension are all phenotypes of the same insulin-resistant 
genotype (Hattersley and Tooke, 1999). A mutation in the glucokinase gene of the fetus 
resulted in reduced birth weight, suggesting that a mutation in this same gene in the 
mother would result in reduced maternal insulin secretion, and therefore hyperglycemia 
(Hattersley et al., 1998). This would then lead to a period of increased fetal growth and 
insulin secretion postpartum (Byrne et al., 1994). These hypotheses were proven valid at 
birth, when it was determined that the effects of these mutations were additive, but Vehlo 
et al. (2000) determined that these effects did not persist into adulthood.  
An alternative insulin-resistant genotype results from an absent allele of a 
polymorphism in the promoter region of the IGF-1 gene, resulting in reduced insulin-
secreting capacity as well as in reduced circulating IGF-1 concentrations, reduced adult 
height, and increased risk of heart attack and Type-2 diabetes (Vaessen et al., 2001, 
2002). Larnkjaer et al. (2009), however, found an inverse relationship between IGF-1 
concentrations at 9 months of age and 17 years of age between breast-fed and formula-
fed humans. A greater IGF-1 serum concentration at 9 months in formula-fed individuals 
corresponded to a reduced IGF-1 concentration at 17 years old (Larnkjaer et al., 2009). 
This finding, that the mutation fixes itself, suggests that the changes that occur in 
hormonal axes are due to metabolic programming, rather than genetic differences. This is 
especially interesting because human babies that were nursed had reduced risk of obesity 
later in life than formula-fed babies (von Kries et al., 2000), suggesting that the mother 
regulates intake of the offspring. The increased IGF-1 serum concentration at 9 months in 
the formula-fed individuals would therefore correspond with increased nutrients and 
increased fetal insulin. Thus, this model is similar to that of a nutrient-restricted fetus 
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being introduced to an environment of adequate nutrition, in terms of metabolic 
programming. This finding lends credence to the Thrifty Phenotype Hypothesis. 
 The Thrifty Phenotype Hypothesis is the more accepted hypothesis, and was 
originally asserted by Hales and Barker (1992). This hypothesis suggests that permanent 
changes in glucose-insulin metabolism stem from effects of poor nutrition during fetal 
and early life (Hales and Barker, 1992). Prenatal modifications to metabolism selectively 
alter the growth rates of body tissues, sparing nutrient availability for the brain at the 
expense of other organs, including the pancreas, kidneys, liver, and lungs (de Boo et al., 
2008; Yuan et al., 2011; Novitskaya et al., 2011). The metabolic setting of these organs is 
also altered by IUGR, which essentially programs the fetus to thrive in an environment 
with poor nutrient availability (Barker, 1997). Thus, poor gestational nutrition enhances 
the ability of the fetus to absorb and use nutrients (Hales and Barker, 1992). Whereas 
these modifications enhance fetal survival, they lead to negative health consequences as 
they persist into adulthood (Wu et al., 2006). This is known as fetal programming, which 
is defined by Lucas (1991) as when a provocation at a vital stage of development results 
in changes that last the lifetime of the individual. It is also known as the developmental 
origins of health and disease (Barker, 1997). The somatotropic axis, as well as glucose 
metabolism and leptin signaling are all potentially reprogrammed during gestation by 
IUGR (Thorn et al., 2011).  
 The Predictive Adaptive Response Hypothesis was asserted by Gluckman and 
Hanson (2006). It is an offshoot of the Thrifty Phenotype Hypothesis and suggests that 
the maternal uterine environment serves as a prediction of the postnatal nutritional 
environment (Gluckman and Hanson, 2006). While the Thrifty Phenotype Hypothesis 
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stresses the negative consequences that IUGR has on long-term animal health, the 
Predictive Adaptive Response Hypothesis views fetal programming as advantageous to 
the offspring. Depending on the external environment, either interpretation can be 
correct. 
Compensatory Growth 
 Due to the thrifty phenotype and fetal programming, IUGR newborns are smaller 
at birth, but tend to undergo rapid postnatal growth, known as compensatory growth, 
once adequate nutrition becomes available (Ong et al., 2000; Tosh et al., 2010). However, 
due to alterations made during fetal programming of metabolism, nutrient partitioning, 
and endocrine regulation, this rapid growth often causes obesity in adulthood in IUGR 
animals (Tosh et al., 2010; Thorn et al., 2011). This results in increased body fat, 
decreased lean muscle mass, increased insulin resistance, and eventually in diabetes (Wu 
et al., 2006). Compensatory growth is defined as a growth rate above that which is 
statistically normal, during a period of time immediately following growth inhibition 
(Boersma and Wit, 1997). As a result, the individual resumes its original growth 
trajectory from before the restriction. Compensatory growth essentially occurs through 
increased feed intake, which increases IGF-1 concentrations above normal (Boersma and 
Wit, 1997). Once the normal trajectory has been achieved, intake decreases, and IGF-1 
concentrations resume to normal (Boersma and Wit, 1997). For this reason, in animals 
undergoing compensatory growth, body weight is inversely correlated to IGF-1 
concentrations (Fall et al., 1995). 
 Compensatory growth also results in obesity and other metabolic disorders 
(Boersma and Wit, 1997; Wu et al., 2006; Bol et al., 2008). An animal programmed to 
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best absorb nutrients in an environment not conducive to growth will be programmed for 
obesity and reduced health when nutrition is plentiful (Bol et al., 2008; Setia and Sridhar, 
2009). When nutrient restriction is maintained postpartum, compensatory growth is 
postponed, and the negative consequences associated with metabolic syndrome do not 
occur (Tosh et al., 2010). It was found that IUGR animals had similar concentrations of 
hepatic IGF-1 mRNA to the control group when nutrient restriction was maintained 
postpartum (Tosh et al., 2010). Therefore, restriction of postpartum nutrition and 
regulation of the rate of compensatory growth may prevent any epigenetic modifications 
related to IUGR that may lead to metabolic syndrome and its negative impacts (Tosh et 
al., 2010). 
Changes to Fetal Growth and Metabolism 
 During gestation, a fetus of an underfed ewe experiences reduced circulating 
concentrations of insulin, IGF-1, IGF-2, and IGFBP-3, along with increased 
concentrations of GH and IGFBP-1 and -2 (Giudice et al., 1995; de Zegher et al., 1997; 
Renaville et al., 2002). At 9 months of age in IUGR rats fed ad libitum postpartum, it was 
noted that an increased concentrations of plasma IGF-1 were present (Tosh et al., 2010). 
In another study, Vonnahme et al., (2003) found that increased concentrations of IGF-1 
coincided with reduced body weight and size at birth in lambs. However, Coupé et al., 
(2012) saw differences in size of rats similar to the Vonnahme group, yet this difference 
was lost by 5 months of age. This is in part due to the effects of compensatory growth 




Changes in Gene Expression 
 Compensatory growth results in increased hepatic IGF-1 mRNA expression (Tosh 
et al., 2010). It is suggested that increased amounts of mRNA are due to IGF-1 histone 
and chromatin structure modifications to the methylation of the fourth lysine residue of 
histone three (H3K4; Tosh et al., 2010). This suggests that compensatory growth results 
in epigenetic changes to chromatin and histone structure. Additionally, there are two IGF-
1 isoforms, which stem from alternative splicing of the six IGF-1 exons; fasting, diabetes, 
and development all result in different transcriptional start sites through epigenetic 
modifications (Adamo et al., 1991; Tosh et al., 2010). Therefore, epigenetic 
modifications to histone structure can alter access of transcriptional machinery to the 
DNA and could therefore cause differential transcription of isoforms, both in terms of 
start site and amount of mRNA transcribed (Cheung and Lau, 2005; Feil, 2006). For 
example, trimethylation of H3K4 has been established as a marker on promoter regions 
of active genes, whereas dimethylation is associated with promoting expression and 
recruitment of transcriptional machinery (Santos-Rosa et al., 2002; Cheung and Lau, 
2005). 
 Rats exhibiting IUGR given adequate nutrition postpartum, displayed increased 
mRNA expression of both isoforms of IGF-1 at 9 months of age (Tosh et al., 2010). This 
is associated with decreased H3K4 dimethylation at the IGF-1 promoters 1 and 5, and 
increased H3K4 at untranslated region 4 (Tosh et al., 2010). However, IUGR rats with 
postpartum feed restriction only displayed increased mRNA expression of IGF-1B at 9 
months of age (Tosh et al., 2010). This coincided with reduced H3K4 demethylation at 
IGF-1 promoter 1 and increased dimethylation at both promoter 2 and untranslated region 
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3 (Tosh et al., 2010). At birth, there was no significant difference in mRNA expression 
between treatment groups, but there was increased H3K4 dimethylation at promoter 1, 
exon 5, and untranslated region 3 in nutrient restricted rats at this time (Tosh et al., 2010). 
 It has been determined in the laboratory that Cited 1 gene knockout mice develop 
late gestational placental insufficiency, as the Cited 1 gene is responsible for trophoblast 
development (Rodriguez et al., 2004). This is one model of experimentally inducing 
IUGR in a fetus. Cited 1 is X-linked, allowing researchers to distinguish placental from 
embryonic effects (Novitskaya et al., 2011). In the Cited 1 knockout model, there was a 
reduction of fetal IGF-1 receptors (IGF-1R) as well as fetal insulin receptors in the 
kidneys, and a reduced number of insulin receptors in the lungs and liver of mice pups 
born to Cited 1 knockout dams (Novitskaya et al., 2011). There was no change in IGF-1R 
in the brain, which means that the change in phosphorylation is due solely to placental 
insufficiency (Novitskaya et al., 2011). The change in phosphorylation in the kidneys and 
lungs was due to alterations of IGF-1 and -2 expression, while liver changes were 
associated with decreased pancreatic insulin secretion (Novitskaya et al., 2011). This 
model of inducing IUGR allows researchers to determine which effects of IUGR are due 
to solely placental insufficiency, and which have more compound causes  
In the sheep model, placental restriction induced by caruncle removal increased 
peri-renal leptin expression, but not receptor expression at day 43 postpartum (De Blasio 
et al., 2010). Plasma leptin concentrations at day 40 in fed lambs correlated with per-
renal leptin expression in both IUGR and control lambs, but with receptor expression 
only in IUGR lambs (De Blasio et al., 2010), suggesting dysregulation between 
circulating leptin concentrations and receptor amounts. Thus, these animals are primed 
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for hyperleptinemia, and leptin insensitivity. In fasted lambs, such a change was not 
noted (De Blasio et al., 2010). Peri-renal leptin expression was positively correlated with 
visceral fat mass, as a percentage of body weight in IUGR lambs (De Blasio et al., 2010). 
Plasma leptin concentration, however, correlated positively with total visceral fat mass, 
and with total visceral fat mass as a percentage of body weight (De Blasio et al., 2010). It 
is also interesting to note that in a 1.5 hour observation period on day 15, leptin 
concentration correlated negatively with the total number of suckling events in lambs 
born to control-fed ewes (De Blasio et al., 2010). In contrast, leptin concentration 
correlated positively with total suckling time in lambs that experienced placental 
restriction (De Blasio et al., 2010). When adjusted for body weight, leptin concentration 
also correlated positively with total number of suckling events in placentally-restricted 
lambs (De Blasio et al., 2010). This points to leptin insensitivity, and the possibility that 
these lambs will become obese later in life. 
Bol et al. (2008) altered protein composition of the diet of rat dams during 
gestation, and induced compensatory growth in pups by reducing the number of pups per 
litter. The group compared adiposity of rats born to dams fed low a protein diet with rats 
born to control-fed dams during gestation (LP rats) and found an increased number of 
preadipocytes in LP animals, and increased Cyclin D1 mRNA expression (Bol et al., 
2008). The preadipocytes from male rat pups at four weeks of age were harvested and 
cultured; it was found that total DNA and protein within the preadipocytes of LP rats at 
days 4, 7, and 9 of culture was increased, suggesting altered adipocyte 
growth/development (Bol et al., 2008). However, no difference was noted at later days of 
culture (Bol et al., 2008). At this time, LP rats also displayed decreased mRNA 
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expression of PPARγ and SREBP-1 mRNA, which are regulators of adipocyte 
differentiation (Hausman et al., 2001; Bol et al., 2008). This makes sense, since 
differentiation and proliferation cannot occur simultaneously (Bol et al., 2008). These 
results suggest that at 4 weeks in vivo, LP rats are experiencing increased proliferation of 
preadipocytes, which will eventually mature into adipocytes, resulting increased total fat 
mass. 
Insulin Resistance/Glucose Intolerance/Type-2 Diabetes 
Offspring that are IUGR due to maternal feed restriction, experience reduced 
insulin concentrations while in-utero, which presents a lack of stimulus for the 
development of the insulin-receptor system (Hales and Barker, 1992; Guidice et al., 
1995). Fewer insulin receptors results in reduced glucose clearance from the blood, and 
therefore increased circulating glucose (Guidice et al., 1995). It is suggested that the 
GLUT4 transporter, which is responsible for glucose uptake into cells, is also impaired 
(Jaquet et al., 2001). This is because in peri-renal fat of lambs energy-restricted in utero, 
proteins for insulin-receptor β (Irβ) and the p110β isofrm of P13-kinase in the 
phosphotidylinositol pathway were increased (Gardner et al., 2005). These proteins are 
responsible for translocating GLUT4 transporters to the cell surface of adipocytes, so 
theoretically, GLUT4 protein should be increased; however, GLUT4 protein was 
decreased (Gardner et al., 2005). In muscle, only the Irβ protein was significantly 
decreased (Gardner et al., 2005). This demonstrates dysregulation between signaling for 
GLUT4 protein in adipose tissue, and its expression. Additionally, GLUT4 expression 
and its mRNA expression in adipose tissue was not stimulated by the presence of 
circulating insulin in humans born IUGR, as it was in controls (Jaquet et al., 2001). 
 20
Impaired GLUT4 transporter function means that adipose tissue is not as capable to clear 
glucose from the circulation and bring it into the cell.  
Yuan et al. (2011) reported that from birth to 15 weeks of age, both glucose 
tolerance and insulin sensitivity decreased in IUGR rats when compared with controls. In 
this experimental design, IUGR was induced by reducing maternal caloric intake by 50% 
from days 11 to 21 (mid-late) gestation (Yuan et al., 2011). At birth, the IUGR group 
exhibited increased glucose tolerance and increased insulin sensitivity, as the fetus was 
programmed to maximize nutrient uptake as a result of a poor gestational environment; 
however, with age, this trend reversed (Yuan et al., 2011). In a glucose tolerance test, in 
which glucose is injected into the blood stream at birth to determine the time it takes for 
glucose clearance and the magnitude of the insulin response, the IUGR group displayed 
increased blood glucose and insulin concentrations at 120 and 180 minutes after glucose 
injection (Yuan et al., 2011). However, by 15 weeks, this same test resulted in increased 
concentrations of both, compared with controls, after only 30 minutes (Yuan et al., 2011). 
At 15 weeks, IUGR rats responded to insulin injection with a 40% decrease in blood 
glucose concentration, compared with the 50% decrease exhibited by the control group, 
suggesting both decreased insulin response and decreased insulin sensitivity in IUGR rats 
(Yuan et al., 2011). The pancreas was harvested from animals of both treatments groups, 
and was found to weigh less as a percentage of body weight in the IUGR group than the 
control group. Long et al. (2009), however, did not observe this trend in cattle. The β 
cells of harvested pancreas were cultured and exposed to two different concentrations of 
glucose (Yuan et al., 2011). It was expected that there would be a greater insulin response 
to the larger concentration of glucose; however the IUGR group displayed significantly 
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reduced insulin response to the greater glucose concentration (Yuan et al., 2011). This 
suggests that in IUGR animals, pancreatic β cells were less developed, or less responsive 
than the control animals. 
In lambs from ewes nutrient restricted to 50% NRC requirements from day 28 to 
78 of gestation, baseline glucose concentrations at 1 day of age were significantly 
increased, but basal insulin was not different (Ford et al., 2007). However, at 250 days of 
age, baseline glucose and insulin concentrations did not differ between IUGR lambs and 
control lambs (Ford et al., 2007). Growth-restricted lambs did exhibit a decreased insulin 
area under the curve (AUC), and a greater AUC for glucose (Ford et al., 2007). This 
suggests reduced insulin sensitivity (Ford et al., 2007). At one year of age, lambs energy-
restricted until day 30 of gestation, and in lambs from ewes underfed from 110 days of 
gestation to parturition, showed similar responses to glucose tolerance tests (Gardner et 
al., 2005). Maximal change in glucose and insulin concentrations and time to return to 
baseline glucose concentrations in response to a glucose challenge were similar as well 
(Gardner et al., 2005). Feed restriction to 50% NRC requirements of ewes during the last 
37 days of gestation results in reduced insulin sensitivity in the offspring at 12 months of 
age (Gardner et al., 2005), because it took longer for the insulin concentration to return to 
baseline after a glucose challenge in these lambs, since less overall insulin was released, 
and less glucose was removed from the blood. 
Obesity 
Growth-restricted rats allowed to feed ad libitum exhibited rapid compensatory 
growth and increased circulating triglyceride concentrations at birth, but decreased 
concentrations of glucose, insulin, and triglycerides at three weeks (Desai et al., 2007). 
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By 9 months, these metabolites were all increased (Desai et al., 2007). Insulin deficiency 
and increased cholesterol were exhibited in rats allowed delayed compensatory growth by 
restricting feed postpartum (Desai et al., 2007). This programmed obesity is perhaps due 
to leptin resistance, as lambs from nutrient-restricted ewes (day 28 to 78 of gestation) had 
increased leptin concentrations (Ford et al., 2007). Leptin has a characteristic peak during 
development that has been found to program its own axis and sensitivity (Yura et al., 
2005). In sheep, this peak is from day 6 to 9 postpartum (Long et al., 2011). In lambs 
from overfed ewes, however, this peak was from days 0 to 4 postpartum (Long et al., 
2011). 
In rats, offspring of obese dams have an amplified and prolonged leptin peak 
when compared with offspring from control dams (Kirk et al., 2009). In rats administered 
leptin before the time of the leptin peak, the number of leptin receptors was reduced in 
the hypothalamus (Toste et al., 2006). Fewer leptin receptors results in a reduced 
response to leptin in these rats, and could result in leptin resistance (Yura et al., 2005). 
IUGR rats experienced an earlier leptin surge than control rats and exhibited increased 
appetite despite increased circulating leptin (Vickers et al., 2000; Yura et al., 2005). Since 
the role of leptin is to decrease appetite, decrease feed intake, and increase activity, this 
finding suggests leptin resistance (Vickers et al., 2000; Yura et al., 2005). 
Lambs with an abnormal leptin peak experienced an increase in appetite, similar 
to the behavior expressed by rats with reduced leptin receptors, and leptin insensitivity 
(Yura et al., 2005; Long et al., 2010, 2011). It is hypothesized that perhaps the early 
leptin peak is due to increased leptin mRNA in adipose tissue (Kirk et al., 2009). It is also 
possible that this is related to increased cortisol in obese sheep compared with the 
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controls. For example Long et al. (2011) reported obese ewes lambed approximately 
three days earlier than control ewes, but are not sure of the reason why. This link is 
suggested because cortisol normally increases during late gestation and at parturition, as 
does plasma leptin and peri-renal mRNA expression (Magyar et al., 1980; O’Connor et 
al., 2007). However, this increase in leptin and leptin mRNA expression does not occur 
when the adrenal glands are removed (O’Connor et al., 2007). Additionally, Mustoe et al. 
(2012) showed that in marmoset monkeys, infants born to mothers with increased 
gestational cortisol for the first trimester of gestation had reduced fetal growth rates. 
However, these high-cortisol infants had more rapid postnatal growth rates than control 
infants, and experienced complete compensatory growth by 540 days of age. Thus it is 
possible that elevated cortisol concentrations are responsible for some sort of fetal 
programming. 
In rats from control-fed dams, circulating leptin was negatively correlated with 
feed consumption, suggesting the proper leptin response (Delavaud et al., 2000).  Rats 
from nutrient-restricted mothers, however, had circulating leptin concentrations that were 
positively correlated with feed consumption, suggesting leptin insensitivity or resistance 
(Delavaud et al., 2000). During severe nutrient restriction, in the form of a two-day fast, 
back, omental, and peri-renal adipose tissue leptin mRNA was decreased in ruminants, 
suggesting a pre-translational regulation due to nutrient uptake (Kumar et al., 1998; 
Tsuchiya et al., 1998). Perhaps a similar response occurs during prolonged nutrient 
restriction while in utero. 
Organ Size 
Intrauterine growth retardation is also characterized by asymmetric organ growth. 
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Organs such as the pancreas, liver, kidney (reduced as a percentage of body weight), and 
lungs (reduced as a percentage of body weight) become reduced in size so that nutrient 
priority is given to the brain (de Boo et al., 2008; Novitskaya et al., 2011). The brain has 
a reduced absolute weight, but it is increased as a percentage of body weight (Novitskaya 
et al., 2011). Vonnahme et al. (2003) found that when corrected for body weight, liver 
weight and left and right heart ventricles were larger in IUGR lambs. This may be due to 
an increase in liver metabolic activity (Vonnahme et al., 2003). Ruminants receive 
glucose primarily via gluconeogenesis, and since IUGR results in reduced blood glucose 
concentration, gluconeogenic enzymes in the fetal liver are increased (Lemons et al., 
1986; Vonnahme et al., 2003). 
Hypertension 
In addition to asymmetric heart growth, IUGR lambs have larger left and right 
ventricles of the heart, suggesting increased ventricular afterload, which requires the 
ventricle to overcome more force during contraction (Vonnahme et al., 2003). This can 
be due to either aortic or pulmonary artery impedence, peripheral vascular resistance, or 
viscosity of the blood (Vonnahme et al., 2003). In this case, Vonnahme et al. (2003) 
suggested that it was to be due to increased placental vascular resistance, as vascularity of 
the placenta did not change in IUGR lambs. 
Growth-restricted lambs nutrient-restricted from early to mid-gestation have a 
reduced number of kidney nephrons, which is associated with hypertension as well 
(Gopalakrishnan et al., 2005). In cattle, Long et al. (2009) reported reduced glomerular 
number in bovines on day 245 of gestation in IUGR calves, despite similar kidney  
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weight, supporting the findings of Gopalakrishnan et al. (2005) that IUGR animals have 
fewer nephrons.  
Change in Tissue Accretion 
Most fetal development involves an increase in cell number, or hyperplasia, 
whereas postnatal development involves an increase in cell size, or hypertrophy. IUGR 
animals have a physiological limit to growth, that is less than their genetic potential due 
to fetal programming of the somatotropic axis (Boersma and Wit, 1997; Rehfeldt and 
Kuhn, 2006). Consequently, bone and muscle will not reach the normal trajectory in an 
IUGR animal with an altered somatotropic axis, even if postnatal compensatory growth 
does occur. Instead, the compensatory growth experienced, will result in an increase in 
size of adipose tissue, due to a change from normal nutrient partitioning once GH and 
IGF-1 concentrations decrease (Boersma and Wit, 1997). De Blasio et al. (2010) found 
increased peri-renal, retroperitoneal, and visceral fat in the carcasses of placentally 
restricted lambs when compared to the control. 
Rehfeldt and Kuhn (2006) examined the effects of birth weight on postnatal 
myogenesis of pigs. In pigs, not only maternal nutrition, but also position in the uterine 
horn, is responsible for the amount of nutrients received (Rehfeldt and Kuhn, 2006; Wu 
et al., 2006). Since hyperplasia of myogenic cells is most prominent in prenatal growth, 
whereas hypertrophy occurs predominantly postnatally, this reduced number of myogenic 
cells limits animal growth for life. It was also determined that as the animals grew, 
piglets with low birth weights experienced supramaximal growth of individual muscle 
fibers, resulting in giant fibers, which grew beyond the parameters of normal growth 
(Rehfeldt and Kuhn, 2006). Therefore, at slaughter, the low birth-weight pigs had not 
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only a greater percentage of organ weight to body weight, as muscle growth was 
restricted, but also had a greater percentage of adipose tissue, and a reduced quality of 
meat (Rehfeldt and Kuhn, 2006). 
Lambs from underfed ewes days 28 to 78 of gestation displayed increased back 
fat (detected via ultrasound) at 140 days of age (Ford et al., 2007). Additionally, while 
LM and semitendinosus muscle weights were similar for IUGR and control lambs, the 
ratio of LM and semitendinosus muscle weights to hot carcass weights was less in IUGR 
lambs (Ford et al., 2007). 
Prevention and Reversal 
Thus far, scientists have been unsuccessful in attempting to prevent or reverse 
IUGR through hormone treatments. However, de Boo et al. (2008) attempted to reverse 
IUGR in sheep by supplementing maternal GH through intramuscular injections. Three 
groups of sheep were used: one control, and two with growth restriction induced twice 
daily by embolization of the uterine arteries (de Boo et al., 2008). One of the IUGR 
groups was treated by GH injection, and the other served as a control and was treated 
with saline injection (de Boo et al., 2008). The IUGR induction reduced animal body 
weight, and increased the mass of the liver, heart, thyroid, and peri-renal fat deposits (de 
Boo et al., 2008).  The GH treatment was able to improve fetal weight and overcome 
decreased chest girth, as well as most of the decreases in organ size (de Boo et al., 2008). 
However, even in GH-treated animals, the brain-to-liver weight ratio remained increased, 
suggesting that exogenous GH treatment was not able to fully normalize organ growth 
(de Boo et al., 2008). Additionally, some of the GH-supplemented lambs were found to 
have severe brain lesions, which may be due to hyperglycemia during gestation (de Boo 
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et al., 2008). Even though this experiment could not fully reverse IUGR, it was the first 
study to suggest that, with more research, it could be possible to use hormone treatments 
to prevent and reverse IUGR in animals (Setia and Sridhar, 2009). 
Summary 
The in-utero environment has lasting effects on offspring growth, specifically 
through alterations in metabolic hormone concentrations as well as in receptor number, 
and hormone response. The mechanisms by which these alterations occur are unknown. 
We are trying to understand the metabolic changes that occur in offspring, both longterm 
and short term as a result of poor maternal nutrition during gestation. This will hopefully 
lead to a better understanding of the mechanisms involved, and ways to avoid negative 
fetal programming in the future. 
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Objectives and Hypotheses 
My objectives in performing this experiment were three-fold. The normal model 
in our laboratory when conducting a fetal programming experiment is to induce 
nutritional insult to the mother during gestation, and then remove one of her lambs at 
birth. The lamb is then bottle-fed until 60 days of age. For the first days postpartum, 
lambs must be fed every 3 hours, which requires a significant work force to ensure 
sufficient nutrition. It would be much more efficient to leave the lamb with the ewe to 
nurse, but there has not yet been a comparison of the differences between bottle-feeding 
and nursing the lambs in the response to nutritional insult to the ewe during gestation. 
Although less expensive and less time consuming, there is the potential for more 
variation in the offspring with nursing, including the nutritional quality of the milk from 
nursing mothers. Thus, the first objective was to compare models of postnatal nutrition 
for fetal programming experiments: bottle-feeding milk replacer (bottle lambs) compared 
with leaving the lamb to nurse from the ewe (suckling lambs).  
The second objective was to determine the long-term effects of poor maternal 
nutrition during gestation, as far as one year after birth. Most of the research focuses on 
short-term effects (90 days of age), but for maintaining herd health, as well as human 
health, knowledge about long-term effects is essential.  
The last objective was to determine if the ewes experienced any long-term affects 
of poor diet. If poor gestational diet affects the ewes long-term, than it has the potential to 
negatively impact the fetus she is carrying during the time of nutritional insult, but also 
has the potential to affect the health of her future offspring. 
Our hypotheses were that there would be no difference in results between bottle-
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fed lambs and suckling lambs. Additionally, we expected that lambs born to overfed and 
nutrient-restricted ewes would be smallerwith a slower growth rate than lambs born to 
control-fed ewes. In addition, these lambs would have alterations in concentrations of 
circulating hormones of the somatotropic axis (GH, IGF-1, IGFBP-2, and -3), and leptin. 
Lastly, we hypothesized that ewes would experience long-term effects of poor gestational 
diet. 
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Materials and Methods 
 For this study, 40 multiparous ewes from the UConn flock were synchronized for 
estrus by intravaginal controlled internal drug release (CIDR) with 300 mg progresterone 
for 11 days (EAZI-BREED CIDR, Pfizer). Upon removal, all ewes were given a single 
20mg IM injection of PGF2α (Dixon et al., 2006). Pregnancy was later confirmed by 
ultrasound.  
 Of these ewes, 36 were selected to use for the study, and were housed in 
individual pens. There were 25 Dorsets, 7 Shropshires, and 4 Southdowns. These animals 
were acclimated to a control diet for 1 week. At 31 days of gestation, each ewe was 
randomly assigned to one of three diets (Vonnahme et al., 2010), 100%, 60%, or 140% of 
NRC 1985 recommendations (n=12 per treatment). The amount fed was based on ewe 
body weight. Leftover feed was removed every day, and weighed to determine daily feed 
intake. Animals were also given ad libitum water. Ewes were fed a complete pelleted 
feed from the Connecticut Farmers’ Co-op, in Manchester, CT. Straw was also provided 
in the morning. Ewes were weighed, and the body condition score (BCS) was determined 
weekly (Russel, 1984).  
 These ewes gave birth to a total of 68 lambs. The average gestation length was 
143.9 days; there was no effect of treatment on length of gestation. The ewe and her 
lambs were housed together in pens to allow for colostrum intake. All of the lambs 
received colostrum from the ewe; if they had not nursed by one hour after birth, lambs 
were intubated and given artificial colostrum. At 24 hours postpartum, 35 lambs were 
removed from the ewe. If two ewes were born to the ewe, the largest ewe lamb was 
removed from the mother. If one ewe and one ram were born, the ram was removed, and 
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if two rams were born, the largest ram was removed. Eighteen of the lambs that were 
removed from their mothers were randomly assigned to be euthanized by Beuthanasia IV 
injection (sodium pentobarbital 390 mg + sodium phenytoin 50 mg/ml) at 0.22 ml/kg at 
this time point (6C, 6R, 6O).  
 The remaining 17 lambs, 6 born to control-fed ewes, 6 born to overfed ewes, and 
5 born to restricted ewes, that were removed from the ewe, were bottle fed Land O’Lakes 
milk replacer at 1.7% of their body weight, as well as ad libitum second cutting hay, and 
water. At 4 weeks, the start of weaning, BT creep feed was also given ad libitum. Body 
weight was measured at birth, and every two days until the lambs were weaned, and then 
every week until slaughter. Crown-rump length and heart girth were measured weekly.  
From birth until the lambs were heavier than 4 kg, 10 mL of blood was collected weekly 
via jugular venipuncture. Once the lambs were heavier than 4 kg, 20 mL of blood was 
collected weekly until slaughter. These lambs were slaughtered at 13 weeks of age. At 
slaughter, there were 6 lambs from control-fed ewes, 4 lambs from overfed ewes, and 4 
lambs from restricted ewes. 
 Of the lambs born, 30 returned with the ewes as part of the UConn flock. There 
were 9 lambs born to both control-fed and overfed ewes, and 12 lambs born to restricted-
fed ewes that were monitored as part of this study. From these lambs, body weight, 
crown-rump length, and heart girth were measured at birth, and then monthly for one 
year. 10 mL blood was collected at birth via jugular venipuncture, and then 20 mL were 
collected monthly for one year. By the end of the year, there were 4 lambs born to 
control-fed ewes, 4 lambs born to overfed ewes, and 6 lambs born to restricted ewes.  
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 After parturition, all 36 ewes were returned to the flock to be maintained for 
another breeding cycle. Body weight was measured at parturition, and then monthly for 
12 months. At these same time points, 20 ml of blood was collected as well. By the end 
of the 12 months, 20 ewes remained: 5 control, 9 restricted, and 6 overfed. Ewes were 
removed from the study if their lamb was sent to auction before it was fully weaned. 
  Blood was collected into 3 different types of tubes: 14 mL was collected into 
uncoated blood tubes, allowed to stand at room temperature for 3 hours to clot, and then 
refrigerated overnight at 4°C before centrifugation. These tubes were used for serum 
collection. An additional 3 ml was collected into a tube coated with heparin, and the 
remaining 3 ml was collected into a tube coated with EDTA. Both of these tubes were 
immediately placed on ice, and centrifuged upon return to the laboratory. These tubes 
were used for plasma collection. Blood samples were centrifuged for 30 minutes at 1,200 
x g at 4°C, and serum and plasma were isolated and frozen at -20°C until used. Serum 
GH (Kazmer et al., 1992), and IGF-1 (Govoni et al., 2002), concentrations were 
quantified (ng/ml) by radioimmunoassay (RIA). Plasma leptin concentrations were 
quantified (ng/ml) by Millipore Multispecies Leptin RIA Kit (Long et al., 2010). IGFBP-
2 and IGFBP-3 were quantified by Western Blot (Freake et al., 2001; Govoni et al., 
2002). Proteins were separated using SDS-PAGE, with serum concentration at 1 µL per 
well in the gel. Proteins were then transferred to a nitrocellulose membrane (BioRad 
Laboratories, Hercules, CA), and incubated overnight with 300,000 cpm of radioactive 
125
 I-IGF-1 (Perkin Elmer, Shelton, CT). Membranes were then washed to remove any 
unbound IGF-1, and the blot was imaged after membrane incubation with a multipurpose 
phosphor screen  (Packard Instrument Company, Meriden, CT). The remaining bound 
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radioactivity was imaged using a Cyclone Storage Phosphor system (Packard Instrument 
Company), and were quantified using OptiQuant software. Digital light units were 
quantified, and values were expressed relative to a bovine standard included on every gel 
as a control. 
 Growth rate was determined by subtracting the body weight at birth from the 
body weight at 9 months of age, and dividing by the number of days of age. Lontitudinal 
measurements of body weight, crown-rump length, heart girth, serum GH, IGF-1, and 
IGFBP-2, and -3, and leptin were analyzed statistically as repeated measures, using a 
model that accounted for repeated samples from the same experimental unit, with the 
mixed model analysis of variance procedure (SAS Inst. Inc., Cary, NC). Multiple 
methods of analysis were used, but the final method was chosen as best fit for the data set 
based on the smallest AIC value. Differences were considered significant if P < 0.05 and 




Suckling vs. Bottle-fed Lambs 
 
 Over time, all lambs increased body weight from 4.5 ± 0.21 kg at birth to 34.7 ± 
0.68 kg at 3 months. At birth, the largest lamb was removed from the ewe and bottle-fed, 
so bottle lambs (n=17) weighed more at birth than suckling lambs (n=30); (5.0 ± 0.17 kg 
vs. 4.3 ± 0.13 kg; P < 0.01). By 1 month the suckling lambs weighed significantly more 
than the bottle lambs (15.4 ± 0.59 kg vs. 10.7 ± 0.75 kg; P < 0.01). This greater body 
weight was maintained (36.6 ± 0.56 kg vs. 30.8 ± 0.73 kg; P < 0.01) through 3 months of 
age (Table 1, Figure 1).  
All lambs increased in size gaining approximately 39.3 ± 1.0 cm in CRL, and 38.9 
± 0.7 cm in heart girth over 3 months. Based on selection criteria, the bottle lambs had a 
larger CRL (48.2 ± 0.9 cm) at birth than the suckling lambs (47.4 ± 0.8 cm), although the 
difference was not statistically significant (P = 0.49). At 1 month, the suckling lambs 
were significantly larger than the bottle lambs (70.9 ± 0.8 cm vs. 61.3 ± 0.9 cm; P < 
0.01). At 3 months of age, the difference in CRL was reduced to almost 5 cm but 
remained significant (89.1 ± 0.8 vs. 83.7 ± 1.1 cm; P < 0.01); (Table 2, Figure 2). Bottle 
lambs had a heart girth that was significantly larger than the suckling lambs (39.6 ± 0.6 
cm vs. 37.6 ± 0.4 cm; P < 0.01) at birth, but by 1 month of age, the suckling lambs had a 
significantly larger heart girth (59.4 ± 0.7 vs. 50.7 ± 0.9 cm; P < 0.01). By 3 months, the 
difference in heart girth was reduced (78.7 ± 0.8 cm vs. 74.5 ± 0.9 cm; P < 0.01), 
however, the suckling lambs remained significantly larger (Table 3, Figure 3).  
At birth, the suckling lambs and bottle lambs had similar concentrations of 
circulating IGF-1 (109 ± 14.9 ng/ml vs. 133.0 ± 19.1 ng/ml, respectively; P = 0.33), as 
 35
this was before treatment implementation. At 1 month, the suckling lambs had a 
significantly greater (P < 0.01) IGF-1 concentration (280.7 ± 22.9 ng/ml) than the bottle 
lambs (64.9 ± 28.4 ng/ml). At 2 and three months, there was no significant difference in 
suckling and bottle lamb IGF-1 concentration (231.5 ± 22.9 ng/ml vs. 173.3 ± 28.7 ng/ml, 
and 211 ± 19.9 ng/ml vs. 177.9 ± 26.5 ng/ml; P = 0.27 and 0.72 respectively). 
 All lambs experienced a decline in GH concentration with age, with suckling 
lambs going from 13.4 ± 3.2 ng/ml at birth to 5.5 ± 3.1 ng/ml at 3 months, and bottle 
lambs going from 11.1 ± 3.4 ng/ml at birth to 3.8 ± 3.4 ng/ml at 3 months. There was no 
difference in circulating GH concentration between bottle lambs and suckling lambs (P = 
0.698; Table 5, Figure 5). 
 Bottle lambs tended to have less circulating IGFBP-3 (111.71 ± 7.3 AU) than 
suckling lambs (130.77 ± 6.4 AU; P = 0.0633). At birth, IGFBP-3 concentrations are 
similar, as expected, but at 1 month, suckling lambs have a significantly increased 
IGFBP-3 concentration (P < 0.01; Table 6, Figure 6). At 2 months, after the start of 
weaning, bottle lambs have more IGFBP-3 than suckling lambs, although not significant 
(P = 0.373).  
There was no significant difference in bottle and suckling lamb leptin 
concentration through 3 months of age (P = 0.58). At birth, bottle lambs had more 
circulating leptin than suckling lambs (1.5 ± 0.2 ng/ml vs. 1.2 ± 0.2 ng/ml). By 3 months 
of age, the suckling lambs had a greater circulating leptin concentration compared with 
the bottle lambs (1.3 ± 0.2 ng/ml vs. 1.1 ± 0.2 ng/ml; P = 0.23; Table 7, Figure 7). 
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Suckling Lambs Long-Term 
 
 All suckling lambs increased in body weight from approximately 4.3 ± 1.5 kg at 
birth to 68.3 ± 2.0 kg at 9 months of age. There was no difference in suckling lamb 
body weight over time (CON vs. RES P = 0.36; CON vs. OVER P = 0.96), with lambs 
born to ewes of all 3 treatment groups gaining an average of 0.24 kg/day. At birth, lambs 
born to control-fed, overfed, and restricted ewes (abbreviated CON, RES, and OVER 
lambs) weighed 4.4 ± 1.6 kg, 4.0 ± 1.4 kg, and 4.6 ± 1.6 kg respectively (CON vs. RES, 
P = 0.92; CON vs. OVER, P = 0.88). At 9 months, these lambs weighed 69.2 ± 1.9 kg, 
66.4 ± 1.8 kg, and 70.4 ± 2.1 kg (CON vs. RES P = 0.66 and CON vs. OVER P =0.29) 
(Table 8, Figure 8). 
 Over the 9-month period, all suckling lambs also increased in size, gaining 
approximately 63.1 ± 2.8 cm in CRL, and 67.3 ± 1.5 cm in heart girth. There was no 
significant difference in CRL between CON, RES, and OVER lambs from birth to 9 
months of age. (P = 0.6374, OVER vs. CON; P = 0.9432, for RES vs. CON); (Table 9, 
Figure 9). Similarly, there was no significant difference in heart girth between OVER and 
CON lambs (P = 0.1622) or between RES and CON lambs (P= 0.4491); (Table 10 
Figure 10). However, at 9 months, Over lambs have a significantly larger (P < 0.01) 
heart girth compared with Con lambs (108.9 ± 1.8 cm vs. 102.8 ± 2.0 cm). 
 Additionally, over time, there was no difference in circulating IGF-1 
concentrations between OVER and CON lambs (144.3 ± 15.4 ng/ml vs. 136.3 ± 14.5 
ng/ml; P = 0.71) or between RES and CON lambs (133.4 ± 13.2 ng/ml vs. 136.3 ± 14.5 
ng/ml; P = 0.88; Table 11, Figure 11). At 1 month, CON lambs have a reduced IGF-1 
concentration compared with both OVER and RES lambs (253.2 ± 28.1 ng/ml vs. 323.2 ± 
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40.5 ng/ml and 270.8 ± 37.9 ng/ml), which is interesting because at birth, CON lambs 
had the highest IGF-1 concentration. This difference is not significant (P = 0.21 and 
0.74). Additionally, at 2 months, OVER lambs had a greater IGF-1 concentration 
compared with CON lambs (P < 0.01). This suggests possible increased intake in OVER 
and RES lambs, and therefore compensatory growth.  
 All suckling lambs experienced an age-related decrease in circulating GH 
concentration. However, there was no significant difference in circulating lamb GH 
concentration between OVER and CON (P = 0.9591) or between RES and CON (P = 
0.7984) lambs at any time point (Table 12, Figure 12).  
 OVER lambs had significantly more IGFBP-3 than CON lambs (167.4 ± 7.3 AU 
vs. 137.7 ± 6.6 AU; P < 0.05), but there was no difference between RES and CON lambs 
(122.2 ± 6.37 AU vs. 137.7 ± 6.6 AU; P = 0.1063). At 6 months, there was a trend for 
RES lambs to have less IGFBP-3 than CON lambs (128.1 ± 19.8 AU vs. 184.6 ± 22.2 
AU; P < 0.1), and at 9 months, RES lambs had significantly less IGFBP-3 than CON 
lambs (116.4 ± 11.8 AU vs. 155.7 ± 13.3 AU; P < 0.05) (Table 13, Figure 13). Although 
at birth, RES lambs tended to have less IGFBP-2 than CON lambs (P < 0.1), there was 
no difference in circulating IGFBP-2 among all lambs over time (16.5 ± 1.4 AU vs. 18.9 
± 1.6 AU; P = 0.2979 for CON vs. RES; 17.4 ± 1.7 vs. 18.9 ± 1.6 AU; P = 0.5364 for 
CON vs. OVER; Table 14, Figure 14). All lambs experienced an age-related decrease in 
IGFBP-2. 
 There was no difference in circulating lamb leptin concentration between OVER 
and CON (P = 0.6635) or between RES and CON (P = 0.1651) lambs (Fig. 12). All 
lambs experienced a leptin peak around 5 months of age, at which point there was a trend 
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for RES lambs to have less circulating leptin than CON lambs (2.8 ± 0.3 ng/ml vs. 2.1 ± 
0.3 ng/ml; P < 0.1) At 6 months, there was no difference in lamb leptin concentration 
(Table 15, Figure 15).  
Ewes 
 At birth, RES ewes weighed significantly less than CON ewes (99.6 ± 3.6 kg vs. 
113.8 ± 3.5 kg; P = 0.01). Once ewes were returned to the flock, 3 days after parturition, 
they were all maintained on a control diet. Even so, OVER ewes maintained a 5 kg 
weight increase OVER the 9 month period, and RES ewes maintained a 7 kg weight 
decrease. There was no significant difference between these body weight differences (P 
= 0.3442 for CON vs. OVER, and 0.1358 for CON vs. RES; Table 16, Figure 16). 
 Over time, OVER ewes had significantly more circulating IGF-1 than CON ewes 
(194.19 ± 129.9 ng/ml vs. 130.1 ± 102.5 ng/ml; P < 0.05), and there was a trend for RES 
ewes to have less circulating IGF-1 than CON ewes at birth, 1 month, and 5 months (P < 
0.1). However, over time, there was no difference between RES and CON ewe IGF-1 
concentration (122.29 ± 61.9 ng/ml vs. 130.1 ± 102.5 ng/ml; P = 0.12; Table 17, Figure 
17).  
 There was no significant difference in circulating GH concentration between 
OVER and CON ewes (2.9 ± 0.9 ng/ml vs. 1.9 ± 0.9 ng/ml; P = 0.4716). However, RES 
ewes had significantly more circulating GH than CON ewes (averaging 4.4 ± 0.8 ng/ml 
vs. 1.9 ± 0.9 ng/ml; P < 0.01; Table 18, Figure 18).  
 OVER ewes maintained a significantly increased IGFBP-3 concentration as long 
as 9 months postpartum compared with CON ewes (408.1 ± 35.5 AU vs. 287.9 ± 43.5 
AU; P < 0.05), but there was no difference between RES (240.1 ± 31.4 AU) and CON 
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(287.9 ± 43.5 AU) ewes (P = 0.4914). All ewe IGFBP-3 concentrations decreased after 
parturition, and began to increase at 6 months (Table 19, Figure 19). At parturition 
OVER ewes had significantly less circulating IGFBP-2 (29.35 ± 2.7 AU vs. 33.2 ± 
3.3AU; P < 0.05), however this difference was not maintained through 9 months, and 
there was no difference over time between CON (24.4 ± 1.7 AU), RES (21.3 ± 1.4 AU), 
and OVER lambs (24.7 ± 1.2 AU) IGFBP-2 concentrations (P = 0.8682 for CON vs. 
RES; P = 0.1687 for CON vs. OVER ) (Table 20, Figure 20. 
 There was a trend for OVER ewes to have more circulating leptin than CON ewes 
(2.6 ± 0.2 ng/ml vs. 1.8 ± 0.3 ng/ml; P < 0.1), but there was no difference in circulating 
leptin concentration between RES and CON ewes (2.0 ± 0.2 ng/ml vs. 1.8 ± 0.3 ng/ml; P 




 Bottle lambs were larger at birth, but suckling lambs grew at a faster rate, and by 
1 month of age, were larger than bottle lambs. They maintained this larger size and 
heavier body weight through 3 months. Suckling lambs had an average daily gain of 0.38 
kg/day compared with 0.3 kg/day for the bottle lambs. From 1 to 3 months of age, it 
appears that the suckling and bottle lambs were growing at the same rate, but from birth 
to 1 month, the suckling lambs have an increased growth rate. Emsen et al. (2004) had 
similar findings: lambs fed a calf milk replacer, although larger at birth, gained less 
weight than lambs left to nurse naturally from the ewe in an arid environment. In our 
study, however, the lambs were not fed calf milk replacer, the bottle lambs were weaned 
later, and ewes were fed significant nutrients during lactation. Emsen et al. (2004) noted 
that bottle lambs maintained their smaller size through 6 weeks of age, 2 weeks post 
weaning in their study. However, it has been shown by Heaney et al. (1982) that lambs 
grow better on lamb milk replacer than calf milk replacer; thus it appears as though the 
Emsen study was conducted to obtain results for a farmer struggling with the cost of 
raising his flock.A similar trend is seen for crown-rump length and heart girth, where 
suckling lambs are larger than bottle lambs by 1 month, and maintain this increased size 
through 3 months of age. 
 At birth, suckling and bottle lambs had similar IGF-1 concentrations, as was 
expected since the lambs were not yet assigned to a treatment at this point. At 1 month of 
age, the suckling lambs had a greater IGF-1 concentration. Increased IGF-1 is associated 
with increased growth rate (Yakar et al., 1999), which supports the increase in body 
weight and body size of the suckling lambs at 1 month of age. From birth to 1 month, the 
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bottle lambs experienced decreased IGF-1. Since IGF-1 is associated with nutritional 
intake (Baumann, 2009), this suggests restricted intake in the bottle lambs, especially 
since IGF-1 concentrations increased after 1 month, the time of the start of weaning. 
After 1 month, IGF-1 concentrations in the bottle lambs increased, and the magnitude of 
the difference in body size and body weight between suckling and bottle lambs decreased 
as well.  
 Associated with this reduction in IGF-1 in the bottle lambs at 1 month of age was 
increased GH. Although not statistically significant, bottle lamb GH concentrations were 
increased at this time point. As the somatotropic axis is regulated through a negative 
feedback loop, GH was increased in an attempt to increase IGF-1 concentrations 
(Giustina et al., 2008). This supports the hypothesis that bottle lamb intake was restricted. 
 Additionally, suckling lambs tended to have increased circulating IGFBP-3 
compared with bottle lambs. A greater IGFBP-3 concentration is associated with an 
increased rate of growth (Govoni et al., 2005; Sabin et al., 2011). Thus the greater 
IGFBP-3 concentration, specifically at 1 month of age, supports our hypothesis that 
suckling lambs had access to more nutrition than the bottle lambs before weaning. At 2 
months, bottle lambs have more circulating IGFBP-3, although not statistically 
significant. This suggests that at the start of weaning, bottle lambs began to experience 
compensatory growth.  
Over time, circulating leptin concentrations in bottle lambs decreased, whereas 
leptin concentration in suckling lambs increased, and by 3 months of age, suckling lambs 
had a greater circulating leptin concentration compared with bottle lambs. Leptin 
concentrations are positively correlated with body weight and adiposity (Delavaud et al., 
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2000), which suggests that the increase in body weight and body size in suckling lambs is 
at least in part due to an increase in adipose tissue, and not just increased muscle tissue. 
To determine if adiposity was increased, BCS was compared in the bottle lambs and 
suckling lambs at 2 and 3 months. The average BCS of bottle lambs for these time points 
was 2.9, whereas average BCS in suckling lambs was 3.1. Although only a slight 
difference, this difference does support the suggestion that the increased body weight in 
the suckling lambs is due to adipose tissue accumulation, and not muscle tissue 
accumulation. 
 Therefore, although the suckling lambs were heavier and larger than the bottle 
lambs, this does not necessarily mean that leaving the lamb to nurse from the ewe is a 
better model of postpartum nutrition for a fetal programming study. Bottle-feeding the 
lambs controls the nutrient amount as well as quality of the milk, and as of yet, there has 
not been any research into how the maternal ability to produce milk is affected after a 
period of nutritional stress. Thus, lambs born to underfed and overfed ewes may 
experience differences in milk quality if left to nurse with the ewe. This would make the 
postnatal diets variable amongst lambs. However, quantity and quality of ewe milk was 
not measured. Therefore, it is possible that for each ewe that gave birth to twins, the lamb 
that returned to the flock is eating enough for two, or at least more than the bottle lambs. 
This is supported by our data, which show that the bottle lambs grew slower before the 
period of weaning than suckling lambs, with reduced IGF-1 concentrations, compared 
with the suckling lambs. This suggests that feeding the bottle lambs milk replacer at 1.7% 
body weight per feeding is not enough nutrition for the bottle lambs. Our hypothesis that 
bottle lambs were not being fed enough pre-weaning is supported by increased growth 
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rates and IGF-1 concentrations after the start of weaning, when access to grain becomes 
available, and when the rumen begins functioning. Our laboratory will continue to study 
this. 
 There was no long-term effect of maternal diet during gestation on lamb body 
weight or body size. This is particularly interesting because in the bottle-fed lambs, 
OVER lambs were significantly larger than CON lambs in all of these linear 
measurements through 3 months of age.  
 There was no significant difference in circulating IGF-1 concentration in lambs 
born to ewes of all 3 treatment groups. However, at birth, CON lambs have greater 
concentrations of circulating IGF-1 than RES or OVER lambs. At 1 month of age, both 
OVER and RES lambs have more IGF-1, and at 2 months, OVER lambs have 
significantly more IGF-1. Although not all of these differences were statistically 
significant, this increase in RES and OVER IGF-1 concentration is potentially due to 
increased intake in an attempt to maintain a normal growth rate. As growth is, in part, 
mediated by IGF-1 concentration, increased IGF-1 does suggest increased growth rate 
(Baumann, 2009). However, there was no difference in lamb body weight to support this. 
There was also no difference in circulating GH concentration, which supports our finding 
that there was no significant difference in circulating IGF-1 concentrations, and does not 
support the idea of compensatory growth. The increased OVER lamb GH concentration 
at 6 months is due to 1 animal with a GH concentration of 19.65 ng/ml, while the average 
concentration of the other 3 lambs is 0.98 ± 0.49 ng/ml. Due to the size of the standard 
deviation, this large point was not considered an outlier, and could not be removed. 
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 OVER lambs had significantly more IGFBP-3 than CON lambs as far as 9 months 
of age. At 6 months, the large difference between OVER and CON lamb IGFBP-3 
concentration is due to one sample that was much larger (538.3 AU) than the others, 
which averaged 257.0 ± 48.8 AU. This point was not considered an outlier, and therefore 
could not be removed. More IGFBP-3 is associated with an increased rate of growth 
(Govoni et al., 2005; Sabin et al., 2011), and as there was no difference in average daily 
gain among CON, RES, and OVER lambs it is possible that increased IGFBP-3 
concentrations in OVER lambs modulated compensatory growth in these animals. At 
birth, there was a trend for RES animals to have reduced IGFBP-2, however over time 
there was no difference in lamb IGFBP-2 concentration. IGFBP-2 is associated inversely 
with animal body mass index (Mattsson et al., 2008), suggesting that there is no 
difference in the ratio of muscle tissue to adipose tissue in these lambs. All lambs 
experienced an age-related decrease in IGFBP-2 concentration. 
There was also no difference in circulating leptin, which was supports the similar 
IGFBP-2 concentrations, lack of compensatory growth, and a lack somatotropic axis 
dysregulation, which was unexpected. We expected that RES and OVER lambs would 
experience somatotropic axis dysregulation due to abnormal concentrations of IGF-1 and 
GH in-utero. Once born, we expected to see compensatory growth in these animals, 
associated with significantly greater leptin concentrations, which would mean an increase 
in adipose tissue accumulation rather than muscle growth. However, differences in IGF-1 
concentration were non-significant, suggested similar nutrient intake among lambs, and 
similar rates of growth. The lack of effect of maternal diet during gestation could be due 
to differences in maternal milk nutrition or due to the time of nutrient stress imposed 
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during gestation. For example, different times of nutrient stress have different effects 
(Vonnahme et al., 2003; Gardner et al., 2005; Ford et al., 2007; Coupé et al., 2012). 
 Lastly, the ewes experienced long-term effects of gestational diet. OVER ewes 
maintained a 5 kg heavier body weight compared with CON ewes as far as 9 months 
postpartum, and RES ewes maintained a 7 kg lighter body weight over the 9 month 
period. Neither of these differences in body weight were statistically significant, 
however. We did expect some initial differences in body weight as the ewes would take 
some time re-alimenting to the control diet to make up for body weight differences. 
However, we were not expecting that body weight would remain different through 9 
months of being maintained on the same diet.  
 We expected that the OVER ewes would display greater IGF-1 concentrations 
short-term, and that RES ewes would display reduced IGF-1 concentrations short-term, 
due to differences in gestational diet. However, since IGF-1 is impacted by nutrition, we 
expected that IGF-1 concentrations would quickly return to normal concentrations among 
the three treatment groups. However OVER ewes had significantly greater circulating 
IGF-1 compared with CON ewes over the 9 months, and there was a trend for RES ewes 
to have reduced circulating IGF-1 at birth, 1 month, and 5 months. For this reason, it is 
particularly interesting that RES ewes had a significantly greater circulating GH 
concentration than CON ewes, but that there was no difference between CON and OVER 
GH concentration. We expected that since OVER ewes displayed greater IGF-1 
concentrations, that they would have had reduced GH, and that since there was no 
significant difference between RES and CON ewe IGF-1 concentrations, there would not 
be a difference in GH concentration. However, this was not the case, and there are times 
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when GH trends between GH concentration and IGF-1 concentration do not match. This 
is perhaps more evidence that the ewes maintain longterm effects of poor gestational diet. 
The increased CON ewe GH concentration at 8 months is due to 1 animal, with a GH 
concentration of 7.74 ng/ml. At 8 months, the remaining CON ewes have an average GH 
concentration of 0.81 ± 0.21 ng/ml. However, due to the magnitude of the standard 
errors, the value can not be considered an outlier, and remained in the dataset. 
 Overfed ewes maintained significantly increased IGFBP-3 concentrations as far 
as 9 months postpartum, possible due to increased intake after parturtion. There was no 
difference between RES and CON ewe IGFBP-3 concentration. All ewe IGFBP-3 
concentrations declined after parturition and began to increase around 6 months, the time 
at which ewes were re-bred and moved from pasture grazing to the barn, where 
supplemental grain was added to ewe diets. IGFBP-3 concentrations continued to 
increase as gestation progressed. At parturition, OVER ewes had significantly less 
IGFBP-2 than CON ewes, which makes sense as IGFBP-2 is inversely related to body 
mass index (Mattsson et al., 2008). However, there was no difference between RES, 
CON, and OVER ewe IGFBP-2 concentration over time.  
Overfed ewes maintained increased circulating leptin concentrations relative to 
the control ewes through 8 months postpartum. This indicates that even as late as 8 
months postpartum, overfed ewes still have more adipose tissue, and are still 
experiencing effects of their gestational diet. After the ewes were returned to the flock 
postpartum, they were maintained as part of the flock; which included re-breeding. At 
this point, the ewes have lambed this year’s offspring, which are very likely to be 
affected by the gestational diets of these ewes last year. Therefore, it does seem that a 
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period of nutritional stress during pregnancy has the potential to affect not only the 
offspring a gestating mother is carrying during the time of nutritional stress, but also all 
future offspring of that animal. 
 In summary, suckling lambs grew to be larger than bottle lambs, and had 
increased concentrations of IGF-1 and leptin, suggesting increased intake. As ewe milk 
quantity or quality was not measured, it is possible that there was variation in intake 
among suckling lambs, making it difficult to compare the merit of the two postpartum 
feeding models for a fetal programming experiment. There was no long-term difference 
in growth or metabolic hormone concentration of suckling lambs, except that OVER 
lambs had more circulating IGFBP-3 than CON lambs. This lack of difference is possibly 
due to variation in postpartum intake due to maternal milk quality and quantity, as well as 
the time of maternal nutrient stress. Lastly, ewes did experience longterm effects of poor 
gestational diet. OVER ewes maintained a non-significant increased weight, and 
significantly more circulating IGF-1, IGFBP-3, and leptin. RES ewes maintained 
significantly increased GH. This suggests that when these ewes lamb again, it is possible 











Table 2: Suckling vs. Bottle Lamb CRL      




48.2 ± 0.9  61.3 ± 0.9  71.6 ± 0.9  83.7 ± 1.1  
 
 




47.4 ± 0.8  70.9 ± 0.8  80.1 ± 0.8  89.1 ± 0.8  
 
 
    
 
P-value 0.488 <0.0001 <0.0001 0.0001 
 
      
At birth, bottle lambs were larger in CRL than suckling lambs, though this difference  
was not significant (P = 0.488), but at 1 month, suckling lambs were approximately 10 cm  
larger than bottle lambs (P < 0.01). This significance remained through 3 months. 
Table 1: Suckling vs. Bottle Lamb Body Weight    
Body 
Weight, kg 




5.0 ± 0.17  10.7 ± 0.75  20.6 ± 0.75  30.8 ± 0.73  
 
      
Suckling 
Lambs 
4.3 ± 0.13  15.4 ± 0.59  26.4 ± 0.59  36.6 ± 0.56  
 
 
    
 
P-value 0.0016 <0.0001 <0.0001 <0.0001 
 
      
At birth, bottle lambs weighed significantly more than suckling lambs (P < 0.01), but at  
1 month, suckling lambs were approximately 5 kg heavier than bottle lambs (P < 0.01). 
This significance remained through 3 
months.    
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Table 3: Suckling vs. Bottle Lamb Heart Girth    
Heart Girth, 
cm 




39.6 ± 0.6  50.7 ± 0.9  64.2 ± 0.9  74.5 ± 0.9  
 
 




37.6 ± 0.4  59.4 ± 0.7  69.9 ± 0.8  78.7 ± 0.8  
 
 
    
 
P-value 0.0061 <0.0001 <0.0001 0.0011 
 
      
At birth, bottle lambs were significantly larger in heart girth than suckling lambs (P < 
0.01), but at 1 month, suckling lambs were approximately 8 cm larger than bottle lambs 






Table 4: Suckling vs. Bottle Lamb IGF-1 Concentration  
IGF-1, 
ng/ml 




133.0 ± 19.1  64.9 ± 28.4  173.3 ± 28.7 177.9 ± 26.5 
 
 




109.1 ± 14.9 280.7 ± 22.9 231.5 ± 22.9 211.0 ± 19.9 
 
 
    
 
P-value 0.3259 <0.0001 0.1156 0.3204 
 
      
At birth, bottle and suckling lambs had similar IGF-1 concentrations (P = 0.326), but at 
1 month, suckling lambs had a significantly increased IGF-1 concentration, to 280.7 ±  
22.9 ng/ml, compared with bottle lambs (P < 0.01). At 3 months, IGF-1 concentrations 














Table 5: Suckling vs. Bottle Lamb GH Concentration    




11.1 ± 3.4 11.2 ± 3.8 4.4 ± 1.3 3.8 ± 3.4 
 
 




13.4 ± 3.2 9.6 ± 3.5 6.4 ± 1.2 5.5 ± 3.1 
 
 
    
 
P-value 0.6154 0.7601 0.2693 0.7173 
 
      
There was no significant difference in bottle and suckling lamb GH concentration from 








Table 6: Suckling vs. Bottle Lamb IGFBP-3 Concentration 
   
IGFBP-3, 
AU 




79.8 ± 15.7 59.6 ± 16.5 200.8 ± 19.7 106.6 ± 16.3 
 
 




66.7 ± 14.5 137.9 ± 15.1 177.8 ± 16.5 140.6 ± 14.8 
 
 
    
 
P-value 0.5417 <0.01 0.373 0.1278 
 
      
Over time, there was a trend for suckling lambs to have more IGFBP-3 than bottle lambs 










Table 7: Suckling vs. Bottle Lamb Leptin Concentration  
Leptin, 
ng/ml 




1.5 ± 0.2 1.4 ± 0.2 0.9 ± 0.2 1.1 ± 0.2 
 
 




1.2 ± 0.2 1.4 ± 0.2 1.1 ± 0.2 1.3 ± 0.2 
 
 
    
 
P-value 0.17 0.69 0.25 0.23 
 
 
     
Although there was no significant difference in bottle and suckling lamb circulating leptin  
concentrations (P = 0.58), bottle lambs had more circulating leptin at birth compared with  
suckling lambs, and less circulating leptin at 3 months, suggesting suckling lambs had  








Table 8: Suckling Lamb Body Weight Over Time    
BW, kg Birth 3 Months 6 Months 9 Months 
 
CON 4.4 ± 1.6 36.8 ± 1.6 60.1 ± 1.8 69.2 ± 1.9 
 
 
    
 
OVER 4.6 ± 1.6 36.9 ± 1.7 60.0 ± 1.9 70.4 ± 2.1 
 
 
    
 
RES 4.0 ± 1.4 35.9 ± 1.5 58.0 ± 1.7 66.4 ± 1.8 
 
 





0.92 0.97 0.97 0.66 
 
CON vs. RES 
P-value 
0.88 0.68 0.34 0.29 
 
      
There was no difference in suckling lamb body weight across the 3 treatment groups, with 
 all lambs gaining approximately 0.24 kg/day over the 9 month period (P = 0.36 for CON 





Table 9: Suckling Lamb CRL      
CRL, cm Birth 3 Months 6 Months 9 Months  
CON 47.5 ± 2.5 87.9 ± 2.4 103.7 ± 1.9 108.3 ± 3.0  
 
     
OVER 46.8 ± 2.6 91.7 ± 2.5 106.2 ± 2.1 111.8 ± 3.0  
 
     
RES 47.7 ± 2.3 87.9 ± 2.2 104.0 ± 1.8 111.2 ± 2.6  
 
     
CON vs. OVER P-
value 
0.85 0.26 0.38 0.41  
CON vs. RES P-
value 0.96 0.97 0.64 0.55  
     
There was no difference in suckling lamb CRL across the 3 treatment groups. (P = 0.943) 




Table 10: Suckling Lamb Heart Girth Over Time    
Girth, cm Birth 3 Months 6 Months 9 Months 
 
CON 37.5 ± 0.9 78.4 ± 1.6 97.4 ± 2.0 102.8 ± 2.0 
 
 
    
 
OVER 38.5 ± 0.9 80.8 ± 1.7 99.1 ± 2.1 108.9 ± 2.0 
 
 
    
 
RES 37.1 ± 2.3 76.9 ± 1.6 94.9 ± 1.8 103.6 ± 1.8 
 
 




0.5 0.33 0.57 0.03 
 
CON vs. RES 
P-value 
0.71 0.52 0.35 0.79 
 
 
     
There was no difference in suckling lamb heart girth across the 3 treatment groups. (P = 





Table 11: Suckling Lamb IGF-1 Concentration    
IGF-1, ng/ml Birth 3 Months 6 Months 9 Months  
CON 137.7 ± 27.5 220.6 ± 24.8 89.1 ± 34.0 89.0 ± 34.0  
 
     
OVER 88.0 ± 29.2 219.1 ± 27.8  85.6 ± 34.3 68.2 ± 34.3  
 
     
RES 100.9 ± 24.9 191.0 ± 24.6  91 ±  28.2 87.5 ±  28.2  
 




0.15 0.97 0.94  0.67  
CON vs. RES 
P-value 
0.23 0.39  0.97 0.97  
    
Over time, there was no difference in circulating IGF-1 concentration in suckling lambs  












Table 12: Suckling Lamb GH Concentration    
GH, ng/ml Birth 3 Months 6 Months 9 Months 
 
CON 10.8 ± 3.0 3.9 ± 3.2 2.4 ± 3.6 2.6 ± 3.6 
 
 
    
 
OVER 10.6 ± 3.2 4.6 ± 3.5 6.2 ± 3.8 1.9 ± 3.7 
 
 
    
 
RES 12.9 ± 2.7 5.5 ± 3.1 3.0 ± 3.2 4.6 ± 3.1 
 
 




0.97 0.89 0.48 0.9 
 
CON vs. RES 
P-value 
0.61 0.72 0.91 0.68 
 
      
There was no difference in circulating GH concentration in suckling lambs over the 9  
month period (P = 0.789 for CON vs. RES; P = 0.959 for CON vs. OVER). All   






Table 13: Suckling Lamb IGFBP-3       
IGFBP-3, AU Birth 3 Months 6 Months 9 Months     
CON 66.3 ± 8.5 139.3 ± 15.8 184.5 ± 22.2 155.8 ± 13.3     
 
      
OVER 54.7 ± 9.1 150.4 ± 17.9 334.0 ± 22.4 138.4 ± 13.8   
 
      
RES 68.7 ± 7.7 132.8 ± 15.8 128.1 ± 19.8 116.4 ± 11.8   
 
      
CON vs. OVER     
P-value 
0.35 0.64 <0.01 0.36   
CON vs. RES      
P-value 
0.84 0.77 0.06 0.03     
      
At birth, CON lambs had more circulating IGFBP-3 than OVER lambs but over time, 
OVER lambs had significantly more IGFBP-3 than CON lambs (P < 0.05). There was no 






Table 14: Suckling Lamb IGFBP-2     
IGFBP-2, AU Birth 3 Months 6 Months 9 Months   
CON 32.1 ± 2.3 19.7 ± 2.2 11.6 ± 3.2 11.9 ± 0.79   
 
      
OVER 28.6 ± 2.4 15.3 ± 2.4 13.7 ± 3.3 12.0 ± 0.79   
 
      
RES 26.9 ± 2.0 18.6 ± 2.1 10.3 ± 2.7 10.4 ±0.64   
 
      
CON vs. OVER     
P-value 
0.29 0.17 0.65 0.98   
CON vs. RES      
P-value 
0.09 0.68 0.77 0.15   
      
There was no difference in circulating IGFBP-2 concentration among CON, RES, and OVER 






Table 15: Suckling Lamb Leptin Concentration    
Leptin, ng/ml Birth 3 Months 6 Months 9 Months 
 
CON 1.4 ± 0.2 1.3 ± 0.2 2.2 ± 0.3 2.4 ± 0.3 
 
 
    
 
OVER 1.1 ± 0.3 1.3 ± 0.3 2.9 ± 0.3 2.7 ± 0.3 
 
 
    
 
RES 1.2 ± 0.2 1.3 ± 0.2 2.2 ± 0.3 2.1 ±  0.3 
 
 





0.37 0.86 0.17 0.56 
 
CON vs. RES 
P-value 
0.65 0.89 0.91 0.6 
 
      
There was no difference in circulating leptin concentration in suckling lambs over the 9 









Table 16: Ewe Body Weight      
BW, kg Birth 3 Months 6 Months 9 Months 
 
CON 113.8 ± 3.5 93.4 ± 3.7 88.1 ± 3.9 94.6 ± 3.8 
 
 
    
 
OVER 121.4 ± 3.5 99.3 ± 3.6 90.2 ± 3.7 97.7 ± 3.6 
 
 
    
 
RES 99.6 ± 3.6 86.3 ± 3.6 82.4 ± 3.6 90.6 ± 3.6 
 
 




0.12 0.27 0.69 0.56 
 
CON vs. RES 
P-value 
0.01 0.17 0.28 0.45 
 
 
     
There was no significant difference in ewe body weigtht, (P = 0.34 CON vs. OVER, and   
0.14 CON vs. RES) however OVER ewes did maintain a greater body weight as far as 9  




Table 17: Ewe IGF-1 Concentration       
IGF-1, ng/ml Birth 3 Months 6 Months 9 Months  
 
CON 361.4 ± 26.5 126.0 ± 31.2 56.5 ± 34.7 89.5 ± 34.7  
 
 
     
 
OVER 568.3 ± 24.7 206.2 ± 26.4 98.5 ± 28.4 104.7 ± 28.4  
 
 
     
 
RES 231.6 ± 23.4 176.2 ± 23.4 58.2 ± 26.3 77.4 ± 26.3  
 
 




<0.0001 0.046  0.35 0.74  
 
CON vs. RES 
P-value 
0.0003 0.19 0.96  0.78  
 
 
     
OVER ewes had a greater circulating IGF-1 concentration than CON ewes (P < 0.05) over the  
9 month period. There was no difference between RES and CON ewe IGF-1 concentration 






Table 18: Ewe GH Concentration      
GH, ng/ml Birth 3 Months 6 Months 9 Months 
 
CON 7.1 ± 2.1 1.5 ± 3.0 1.3 ± 3.3 0.8 ± 3.3 
 
 
    
 
OVER 5.8 ± 2.2 1.6 ± 2.8 1.1 ± 2.8 1.8 ± 2.8 
 
 
    
 
RES 25.5 ± 2.1 2.1 ± 2.4 2.4 ± 2.4 1.5 ± 2.4 
 
 





0.66 0.96 0.96 0.8 
 
CON vs. RES 
P-value 
<0.01 0.85 0.79 0.86 
 
 
     
RES ewes had a greater circulating GH concentration than CON ewes (P < 0.01), but there 




Table 19: Ewe IGFBP-3 Concentration      
IGFBP-3, AU Birth 3 Months 6 Months 9 Months 
 
CON 319.8 ± 107.7 102.8 ± 44.2 225.7 ± 95.9 503.2 ± 
105.7  
 
    
 
OVER 622.1 ± 87.9 186.1 ± 36.1 294.4 ± 78.3 529.7 ± 86.4 
 
 
    
 
RES 206.3 ± 81.1 127.9 ± 31.9 231.1 ± 67.8 434.8 ± 74.8 
 
 




0.03 0.15 0.58 0.84 
 
CON vs. RES 
P-value 
0.4 0.64 0.96 0.6 
 
 
     
OVER ewes maintained a significantly increased IGFBP-3 concentration as far as 9 months 
postpartum compared with CON ewes (P < 0.05).There was no difference between RES and 









Table 20: Ewe IGFBP-2 Concentration      
IGFBP-2, AU Birth 3 Months 6 Months 9 Months 
 
CON 33.2 ± 3.3 19.4 ± 3.3 22.8 ± 3.3 22.0 ± 3.3 
 
 
    
 
OVER 29.3 ± 2.7 20.9 ± 2.7 21.1 ± 2.7 13.6 ± 2.7 
 
 
    
 
RES 32.5 ± 2.3 21.1 ± 2.3 28.0 ± 2.3 17.3 ± 2.3 
 
 





0.03 0.15 0.58 0.84 
 
CON vs. RES 
P-value 
0.4 0.64 0.96 0.6 
 
 
     
At parturition, OVER ewes had significantly less circulating IGFBP-2 (P < 0.05), however 
there was no difference in ewe IGFBP-2 concentration maintained through 9 months 





Table 21: Ewe Leptin Concentration      
Leptin, ng/ml Birth 3 Months 6 Months 9 Months 
 
CON 1.8 ± 0.3 1.5 ± 0.5 1.4 ± 0.5 1.4 ± 0.5 
 
 
    
 
OVER 2.6 ± 0.3 2.7 ± 0.4 2.0 ± 0.4 2.3 ± 0.4 
 
 
    
 
RES 2.1 ± 0.3 1.7 ± 0.3 1.8 ± 0.3 1.9 ± 0.3 
 
 





0.08 0.03 0.31 0.16 
 
CON vs. RES 
P-value 
0.57 0.72 0.49 0.4 
 
 
     
OVER ewes tended to have more leptin over time than CON ewes (P <0.1), but there 
was no difference between CON and RES ewes (P =0.42).  











































































Figure 1. Suckling lambs, although slightly lighter at birth, weighed 
approximately 5 kg more at 1 month of age than the bottle lambs. This 5 
kg weight difference was maintained through 3 months of age. * indicates 
P < 0.01 
Figure 2. Suckling lambs experienced an increase in the rate of growth 
from birth to 1 month of age compared with the bottle lambs. Thus at 1 
month of age, they were 10 cm larger than the bottle lambs. At 3 months, 






























































Figure 3. Suckling lambs experienced an increase in the rate of growth 
from birth to 1 month of age compared with the bottle lambs. At 1 month 
of age, they were 8 cm larger than the bottle lambs. At 3 months, this 
difference was reduced to 4 cm, but was still significant. * indicates P < 
0.01 
Figure 4. Suckling lambs experienced an increase in IGF-1 concentration 
from birth to 1 month of age compared with the bottle lambs, who 
experienced a decrease. At 1 month of age, suckling lambs had an IGF-1 
concentration that was greater than bottle lambs by 215 ng/ml. This 
difference was less at 2 months of age, around the time of weaning, and 



























































Figure 5. All lambs experienced a decrease in GH concentration with age. 
At 1 month, bottle lambs had an increased GH concentration compared 
with the suckling animals, but this difference was not significant (P = 
0.69). This is possibly because of the reduced IGF-1 concentration at this 
time.  
  * 
# 
Figure 6. Over time, bottle lambs tended to have a reduced concentration 
of circulating IGFBP-3 compared with suckling lambs (P = 0.0633).  
Suckling lamb IGFBP-3 concentration appeared to increase rapidly at 1 
month of age, and at 2 months, bottle lamb IGFBP-3 concentration 
increased, and caught up to suckling lamb IGFBP-3 concentration. * 
indicates P < 0.05; # indicates 0.05 < P < 0.1 
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Figure 7. Suckling lambs experienced an increase in leptin concentration 
from birth to 1 month of age while bottle lambs experienced a decrease. At 
1 month of age, suckling lambs had an increased leptin concentration, 
which was maintained through 3 months. This greater concentration was 



























Figure 8. There was no difference in body weight between CON and 
RES lambs (P = 0.36) or between CON and OVER lambs (P = 0.96) over 
the 9 month period. Lambs from all 3 treatment groups gained an 
average of 0.24 kg/day.  
Figure 9. There was no difference in crown-rump length between CON and 
RES lambs (P = 0.94) or between CON and OVER lambs (P = 0.64) over the 






































































Figure 10. There was no difference in heart girth between CON and RES, 
lambs (P = 0.45) or between CON and OVER lambs (P = 0.16)over the 9 
month period.  
Figure 11. There was no overall difference in circulating IGF-1 between 
CON and RES lambs (P = 0.88) or between CON and OVER lambs (P = 0.71) 
over the 9 month period. However at 2 months, OVER lambs had 
significantly more (P < 0.05) IGF-1 than CON lambs. Average lamb IGF-1 




























































Figure 12. There was no overall difference in circulating GH between CON 
and RES lambs (P = 0.80) or between CON and OVER lambs (P =  0.96) 
over the 9 month period. Lambs from all treatment groups experienced an 
age-related decrease in GH concentrations. Average lamb GH 
concentration was 4.03 ± 3.9 ng/ml. 
Figure 13. OVER lambs had greater circulating concentrations of  IGFBP-3 
than CON lambs (P < 0.05) over time, and at 6 (P = 0.06) and 9 months (P < 
0.05), RES lambs have less IGFBP-3 than CON lambs. * indicates P < 0.05;  

































































Figure 14. At birth, there was a trend for RES lambs to have less IGFBP-2 
than CON lambs (P < 0.1). However, there was no difference in suckling 
lamb IGFBP-2 concentration over time (P = 0.2979 for CON vs. RES; P = 
0.5364 for CON vs. OVER). # indicates 0.05 < P < 0.1 
Figure 15. There was no overall difference in circulating leptin among 
CON, RES, and OVER lambs over the 9 month period. Lambs from all 
treatment groups had an average leptin concentration of 1.9 ng/ml. 
However, at 5 months, RES lambs had significantly more (P < 0.05) 

































































Figure 16. There was no overall significant difference in ewe body weight 
between birth and 9 months postpartum. However, RES ewes did 
maintain a 7 kg reduced body weight, and OVER ewes maintained a 5 kg 
body weight increase over CON ewes for the 9 months. 
Figure 17. Over time, OVER ewes had a greater circulating IGF-1 
concentration than CON ewes (P < 0.05), but there was no difference 
between RES ewes and CON ewes (P = 0.12) through 9 months 
postpartum. At birth, 1 month, and 5 months RES ewes tended to have 
reduced circulating IGF-1 (P < 0.1). CON ewes averaged an IGF-1 
concentration of 151.7 ± 13.6 ng/ml, OVER ewes averaged a concentration 
of 192.53 ± 11.9 ng/ml, and RES ewes averaged a concentration of 123.35 









































































































Figure 18. Over time, RES ewes had a greater circulating GH concentration 
than CON ewes (4.19 ± 7.72 ng/ml vs. 2.09 ± 2.39 ng/ml; P < 0.01), but 
there was no difference between OVER (1.78 ± 1.8 ng/ml)and CON ewes 
(P = 0.47). This figure does not include GH concentrations at birth because 
the concentration was no much larger for RES ewes, that it skewed the 




















































Figure 19. OVER ewes had significantly more IGFBP-3 than CON ewes 
as far as 9 months postpartum  (P < 0.05). There was no difference 
between RES and CON ewe IGFBP-3 concentration (P = 0.4914). * 
indicates P < 0.05 
 Figure 21. OVER ewes tended to have more circulating leptin over time 
than CON ewes (P < 0.1). There was no difference between CON and RES 
ewe leptin concentration (
averaged leptin concentrations of 1.76 ng/ml, RES ewes averaged 1.99 















































Figure 20. At parturition, OVER ewes had significantly less IGFBP
than CON ewes (
maintained over time among all ewes (
0.1687 for CON vs. OVER). * indicates 
P = 0.42). Over the 9 months, CON ewes 
P < 
2 3 4 5 6 7 8 9
Months Postpartum






P < 0.05). However there was no difference 
P = 0.8682 for CON vs. RES; 













Adamo, M.L.; Haya, B.H.; Leroith, D.; Roberts Jr., C.T. (1991). Transcription initiation in 
the two leader exons of the rat IGF-I gene occurs from disperse versus localized sites. 
Biochemical and Biophysical Research Communications. 176(2): 887-93. 
 
Barker D.J.P. (1997). Maternal nutrition, fetal nutrition, and disease in later life. 
Nutrition.;13(9):807-13. 
 
Baumann, G.P (1994). Growth hormone-binding proteins: state of the art. Journal of 
Endocrinology.141:1–6. 
 
Baumann GP. (2009) Growth hormone isoforms. Growth Horm IGF Res; 19:333–340. 
 
Bauer, M.K.; Breier, B.H.; Harding, J.E.; Veldhuis, J.D.; Gluckman, P.D. (1995). The fetal 
somatotropic axis during long term maternal undernutrition in sheep: evidence for 
nutritional regulation in utero. Endocrinology. 136(3): 1250-7. 
 
Bell, A.W. and Ehrhardt, R.A. (2002). Regulation of placental nutrient transport and 
implications for fetal growth. Nutrition Research Reviews. 15. 211-30 
doi:10.1079/NRR200239. 
 
De Blasio, M.J.; Blache, D.; Gatford, K.L.; Robinson, J.S.; Owens, J.A. (2010). Placental 
restriction increases adipose leptin gene expression and plasma leptin and alters their 
relationship to feeding activity in the young lamb. Pediatric Research. 67(6): 603-8. 
 
Bloomfield, F.H.; van Zijl, P.L; Bauer, M.K.; Phua, H.H.; Harding, J.E. (2006). Effect of 
pulsatile growth hormone administration to the growth-restricted fetal sheep on 
somatrophic axis gene expression in fetal and placental tissues. American Journal of 
Physiology-Endocrinology and Metabolism. Doi: 10.1152/ajpendo.00045.2006. 
 
Boersma, B. and Wit, J.M. (1997). Catch-up growth. Endocrine Reviews. 18(5): 646-61. 
doi: 10.1210/er.18.5.646. 
 
Bol, V.V.; Reusens, B.M.; Remacle, C.A. (2008). Postnatal catch-up growth after fetal 
protein restriction programs proliferation of rat preadipocytes. Obesity. 16(12). 
http://dx.doi.org/10.1038/oby.2008.417. 
 
de Boo, H. A.; Eremia, S.C.; Bloomfield, F.H.; Oliver, M.H.; Harding, J.E. (2008). 
Treatment of intrauterine growth restriction with maternal growth hormone 
supplementation in sheep. American Journal of Obstetrics and Gynecology; 199 
(5):559.e1-559.e9. 
 
Breier, B.H. (1999). Regulation of Protein and Energy Metabolism by the Somatotropic 
Axis.  Domestic Animal Endocrinology.  17: 209-218.   
 
 71
Byrne, M.M.; Sturis, J.; Clément, K; Vionnet, N.; Pueyo, M.E.; Stoffel, M.; Takeda, J.; 
Passa, P.; Cohen, D.; Bell, G.I. (1994). Insulin secretory abnormalities in subjects with 
hyperglycemia due to glucokinase mutations. Journal of Clinical Investigation. 93(3): 
1120-1130. 
 
Chan, S.S.; Schedlich, L.J.; Twigg, S.M.; Baxter, R.C. (2009). Inhibition of adipocyte 
differentiation by insulin-like growth factor-binding protein-3. Am J Phys Endo Met. 
296(4) E654-63 doi: 10.1152/ajpendo.90846.2008. 
 
Chan, S.S.; Twigg, S.M.; Firth, S.M.; Baxter, R.C. (2005). Insulin-like growth factor 
binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrin Met. 90(12) 
6588-95. 
 
Cheung, P. and Lau, P. (2005). Epigenetic regulation by histone methylation and histone 
variants.  Molecular Endocrinology. 19(3): 563-73. 
 
Coupé, B; Grit, I.; Hulin, P.; Randuineau, G.; Parnet, P.; (2012). Postnatal growth after 
intrauterine growth restriction alters leptin signal and energy homeostasis. PLoS ONE. 
7(1): e30616. doi:10.1371/journal.pone.0030616 
 
Delavaud, C.; Bocquier, F.; Chilliard, Y.; Keisler, D.H.; Gertler, A.; Kann, G. (2000). 
Plasma leptin determination in ruminants: effect of nutritional status and body fatness on 
plasma leptin concentration assessed by a specific RIA in sheep. The Journal of 
Endocrinology. 165: 519-526. 
 
Desai, M.; Gayle, D.; Babu, J.; Ross, M.G. (2007). The timing of nutrient restriction during 
rat pregnancy/lactation alters metabolic syndrome phenotype. American Journal of 
Obstetrics and Gynecology. 196(6): 555e1-555.e7. doi: 10.1016/j.ajog.2006.11.036 
 
Dixon, A.B.; Knights, M.; Pate, J.L.; Lewis, P.E.; Inskeep, E.K. (2006). Reproductive 
performance of ewes after 5-day treatment with intravaginal inserts containing 
progesterone in combination with injection of prostaglandin f2alpha. Reprod Domest 
Anim. 41(2): 142-8. 
 
Dyer, C.J.; Simmons, J.M.; Matteri, R.L.; Keisler, D.H. (1997). Leptin receptor mRNA is 
expressed in ewe anterior pituitary and adipose tissues and is differentially expressed in 
hypothalamic regions of well-fed and feed-restricted ewes. Domestic Animal 
Endocrinology. 14(2): 119-28. 
 
Emsen, E.; Yaprak, M.; Bilgin, O.C.; Emsen, B.; Ockerman, H.W. (2004). Growth 
performance of Awassi lambs fed calf milk replacer. Small Ruminant Research. 53(1-2): 
99-102. doi: http://dx.doi.org/10.1016/j.smallrumres.2003.08.018 
 
Fall, C.H.; Pandit, A.N.; Law, C.M.; Yajnik, C.S.; Clark, P.M.; Breier, B.; Osmond, C.; 
Shiell, A.W.; Gluckman, P.D.; Barker, D.J. (1995). Size at birth and plasma insulin-like 
growth factor-1 concentrations. Archives of Disease in Childhood. 73(4): 287-93. 
 72
 
Feil, R. (2006). Environmental and nutritional effects on the epigenetic regulation of genes. 
Mutation Research. 600 (1-2): 46-57. 
 
Ford, S.P.; Hess, B.W.; Schwope, M.M.; Nijland, M.J.; Gilbert, J.S.; Vonnahme, K.A.; 
Means, W.J.; Han, H.; Nathanielsz, P.W. (2007) Maternal undernutrition during early to 
mid-gestation in the ewe results in altered growth, adiposity, and glucose tolerance in 
male offspring. Journal of Animal Science. 85: 2385-94. doi:10.2527/jas.2005-624 
 
Freake, H.C.; Govoni, K.E.; Guda, K.; Huang, C.; Zinn, S.A. (2001). Actions and 
interactions of thyroid hormone and zinc status in growing rats. J Nutr. 131(4): 1135-41.  
 
Freemark, M. (2006). Regulation of maternal metabolism by pituitary and placental 
hormones: roles in fetal development and metabolic programming. Horm Res Paediatr; 
65 (Suppl 3):41–49.  
 
Gardner, D.S.; Tingey, K.; Van Bon, B.W.M.; Ozanne, S.E.; Wilson, V.; Dandrea, J.; 
Keisler, D.H.; Stephenson, T.; Symonds, M.E. (2005). Programming of glucose-insulin 
metabolism in adult sheep after maternal undernutrition. American Journal of Physiology, 
Regulatory, Integrative, and Comparative Physiology. 289 (4): R947-954. 
 
Garten, A.; Schuster, S.; Kiess, W. (2012). The insulin-like growth factors in adipogenesis 
and obesity. Endocrinology and Metabolism Clinics in North America. 41(2): 283-95 
 
Giudice, L.C.; de Zegher, F.; Gargosky, S.E.; Dsupin, B.A.; de las Fuentes, L.; Crystal, 
R.A.; Hintz, R.L.; Rosenfeld, R.G. (1995). Insulin-like growth factors and their binding 
proteins in the term and preterm human fetus and neonate with normal and extremes of 
intrauterine growth. The Journal of Clinical Endocrinology and Metabolism. 80(5): 1548-
55. 
 
Giustina, A., Mazziotti, G., Canalis, E. (2008). Growth hormone, insulin-like growth 
factors, and the skeleton. Endocrine Reviews. 29(5): 535-559).  
 
Gluckman, P.D.; Butler, J.H.; Comline, R.; Fowden, A. (1987). The effects of 
pancreatectomy on the plasma concentrations of insulin0like growth factors 1 and 2 in 
the sheep fetus. Journal of Developmental Physiology. 9(1): 79-88. 
 
Gluckman, P.D. and Hanson, M.A. (2004). Living with the past: evolution, development, 
and patterns of disease. Science 305(5691): 1733-1736. doi: 10.1126/science.1095292 
 
Gluckman, P.D. and Hanson, M. A. (2006). The consequences of being born small – an 
adaptive perspective. Hormone Research 2006; 65(3): 5–14. 
 
Gluckman, P.D. and Pinal, C.S. (2003) Regulation of fetal growth by the somatotropic axis. 
The Journal of Nutrition. 133(5); 1741S-1746S. 
 
 73
Gopalakrishnan, G.S.; Gardner, D.S.; Dandrea, J.; Langley-Evans, S.C.; Pearce, S.; Kurlak, 
L.O.; Walker, R.M.; Seetho, I.W.; Keisler, D.H.; Ramsay, M.M.; Stephenson, T.; 
Symonds, M.E.; (2005). Influence of maternal pre-pregnancy body composition and diet 
during early-mid pregnancy on cardiovascular function and nephron number in juvenile 
sheep. British Journal of Nutrition. 94(6):938-47. 
 
Govoni, K.E.; Baylink, D.; Mohan, S.; (2005). The multi-functional role of insulin-like 
growth factor binding proteins in bone. Pediatric Nephrology. 20(3) 261-268. doi 
10.1007/s00467-004-1658-y. 
 
Govoni, K.E., Hoagland, T.A., Zinn, S.A., (2003).  The ontogeny of the somatotropic axis 
in male and female Hereford calves from birth to one year of age.  Journal of Animal 
Science. 81: 2811-2817.   
 
Govoni, K.E.; Tian, X.C.; Kazmer, G.W.; Taneja, M.; Enright, B.P.; Rivard, A.L.; Yang, X.; 
Zinn, S.A. (2002). Age-related changes of the somatotropic axis in cloned Holstein 
calves. Biol of Reprod. 66: 1293-8. 
 
Hales, C.N. and Barker, D.J.P. (1992). Type 2 (non-insulin-dependent) diabetes mellitus: 
the thrifty phenotype hypothesis. Diabetologia 35: 595-601. 
 
Hattersley, A.T.; Beards, F.; Ballantyne, E.; Appleton, M.; Harvey, R.; Ellard, S. (1998). 
Mutationsin the glucokinase gene of the fetus result in reduced birth weight. Nature 
Genetics. 19(3): 268-70. doi:10.1038/953.  
 
Hattersley, A.T. and Tooke J.E. (1999). The fetal insulin hypothesis: an alternative 
explanation of the association of low birth-weight with diabetes and vascular disease. 
Lancet; 353:1789 – 1792. 
 
Hausman, D.; DiGirolamo, M.; Bartness, T.; Hausman, G.; Martin, R. (2001). The biology 
of white adipocyte proliferation. Obesity Reviews. 2: 239–59. 
 
Heald, A.H.; Kaushal, K.; Siddals, K.W.; Rudenski, A.S.; Anderson, S.G.; Gibson, J.M. 
(2006). Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the 
metabolic syndrome. Exp Clin Endocrinol Diabetes. 114(7): 371-6. 
 
Heaney, D.P.; Shrestha, J.N.B.; Peters, H.F. (1982) Potential alternatives to lamb milk 
replacer for the artificial rearing of lambs. Canadian Journal of Animal Science. 62(4): 
1135-42. doi:10.4141/cjas82-133 
 
Igout, A.; Frankenne, F.l L’Hermite-Balériaux, M.; Martin, A.; Hennen, G. (1995). 
Somatogenic and lactogenic activity of the recombinant 22kDa isoform of human 





Isaksson, O.G.; Lindahl, A.; Nilsson, A.; Isgaard, J. (1987). Mechanism of the stimulatory 
effect of growth hormone on longitudinal bone growth. Endocrine Reviews. 8: 426-
438.  
 
Jaquet, D.; Vidal, H.; Hankard, R.; Czernichow, P.; Levy-Marchal, C. (2001). Impaired 
regulation of glucose transporter 4 gene expression in insulin resistance associated with 
in utero undernutrition. Journal of Clinical Endocrinology and Metabolism. 86(7): 3266-
71. 
 
Jehle, P.M.; Schulten, K.; Schulz, W.; Jehle, D.R.; Stracke, S.; Manfras, B.; Boehm, B.; 
Baylink, D.J.; Mohan, S. (2003). Serum levels of insulin-like growth factor (IGF)-I and 
IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in 
osteoporosis patients. European Journal of Internal Medicine. 14(1): 32-38. 
 
Kawai, M. and Rosen, C.J. (2012). The Insulin-Like Growth Factor System in Bone: Basic 
and Clinical Implications. Endocrinology and Metabolism Clinics of North America. 
41(2) 323-333. http://dx.doi.org/10.1016/j.ecl.2012.04.013 
 
Kazmer, G.W.; Zinn, S.A.; Rycroft, H.; Campbell, R.M. (1992). Serum growth hormone in 
and semen characteristics of proven AI dairy sires after administration of growth 
hormone-releasing factor. Can J Anim Sci 72: 959-63. 
 
Kirk, S.L.; Samuelsson, A.M.; Argenton, M.; Dhonye, H.; Kalamatiano, T.; Poston, L. 
(2009). Maternal obesity induced by diet in rats permanently influences central processes 
regulating food intake in offspring. PLoS ONE 4: e5870. 
 
von Kries R, Koletzko B, Sauerwald T, von Mutius E. (2000). Does breast-feeding protect 
against childhood obesity? Adv Exp Med Biol. 478:29–39 
 
Kumar, B.; Francis, S.M.; Suttie, J.M.; Thompson, M.P. (1998). Expression of obese 
mRNA in genetically lean and fat selection lines of sheep. Comparative Biochemistry 
and Physiology Part B 120: 543-548. 
 
Larnkjaer A, Ingstrup H.K., Schack-Nielsen L., Hoppe C., Mølgaard C., Skovgaard I.M., 
Juul A., Michaelsen K.F. (2009). Early programming of the IGF-I axis: Negative 
association between   IGF-I in infancy and late adolescence in a 17-year longitudinal 
follow-up study of healthy subjects. Growth Hormone and IGF Research; 19: 82 – 86. 
 
Laron, Z.; Pertzelan, A.; Mannheimer, S. (1966). Genetic pituitary dwarfism with high 
serum concentration o fgrowth hormone—a new inborn error of metabolism? Isr J Med 
Sci 2(2): 152-5. 
 
Lea, R.G.; Hannah, L.T.; Redmer, D.A.; Aitken, R.P.; Milne, J.S.; Fowler, P.A.; Murray, 
J.F.; Wallace, J.M. (2005). Developmental Indices of nutritionally induced placental 




Lemons, J.A.; Moorehead, H.C.; Hage, G.P. (1986). Effects of fasting on gluconeogenic 
enzymes in the ovine fetus. Pediatr Res. 20(7): 676-9. 
 
Liu, J.P.; Baker, J.; Perkins, A.S.; Robertson, E.J.; Efstratiadis, A. (1993). Mice carrying 
null mutations of the genes encoding insulin-like growth factor 1 (IGF-1) and type 1 IGF 
receptor (Igf1r). Cell Press. 75(1): 59-72. 
 
Long, N.M.; Ford, S.P.; Nathanielsz, P.W. (2011). Maternal obesity eliminates the neonatal 
lamb plasma leptin peak. Journal of Physiology. 589 (Pt 6):1455-62. 
 
Long, N.M.; George, L.A.; Uthlaut, A.B.; Smith, D.T.; Nijland, M.J.; Nathanielsz, P.W.; 
Ford, S.P. (2010). Maternal obesity and increased nutrient intake before and during 
gestation in the ewe results in altered growth, adiposity, and glucose tolerance in adult 
offspring. Journal of Animal Science. 88: 3546–53. 
 
Long, N.M.; Vonnahme, K.A.; Hess, B.W.; Nathanielsz, P.W.; Ford, S.P. (2009). Effects of 
early gestational undernutrition on fetal growth, organ development, and placentomal 
composition in the bovine. Journal of Animal Science. 87(6): 1950-9. 
 
Longtine, M.S. and Nelson, D.M. (2011). Placental dysfunction and fetal programming: the 
importance of placental size, shape, histopathology, and molecular composition. 
Seminars in Reproductive Medicine. 29(3); 187-96. 
 
Lucas, A. (1991) Programming by early nutrition in man. Ciba Foundation 
Symposium;156:38–50. discussion 50-35. http://www.ncbi.nlm.nih.gov/pubmed/1855415. 
 
Magyar, D.M.; Fridshal, D.; Elsner, C.W.; Glatz, T.; Eliot, J.; Klein, A.H.; Lowe, K.C.; 
Buster, J.E.; Nathanielsz, P.W. (1980). Time-trend analysis of plasma cortisol 
concentrations in the fetal sheep in relation to parturition. Endocrinology 107: 155–9 
 
Mannik, J.; Vaas, P.; Rull, K.; Teesalu, P.; Rebane, T.; Laan, M. (2010). Differential 
expression profile of growth hormone/chorionic somatomammotropin genes in placenta 
of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab; 95:2433–
2442. 
 
Mattsson, A.; Svensson, D.; Schuett, B.; Osterziel, K.J.; Ranke, M.B. (2008). 
Multidimensional reference retions for IGF-1, IGFBP-2 and IGFBP-3 concentrations in 
the serum of healthy adults. Growh Horm IGF Res. 18(6): 506-16. Doi: 
10.1016/j.ghir.2008.04.005. 
 
Melmed, S.; Braunstein, G.D.; Horvath, E.; Ezrin, C.; Kovacs, K. (1983). Pathophysiology 
of Acromegaly. Endocrine Reviews. 4(3): 271. 
 
 76
Mohan, S.; Richman, C.; Guo, R.; Ammar, Y.; Donahue, L.R.; Wer-gedal, J.; Baylink, D.J. 
(2003). Insulin-like growth factor regulates peak bone mineral density in mice by both 
growth hormone-dependent and independent mechanisms. Endocrinology. 144: 929-936. 
 
Murphy, V.E., Smith, R., Giles, W.B., Clifton, V.L. (2006). Endocrine regulation of human 
fetal growth: the role of the mother, placenta, and fetus. Endocr Rev; 27:141–169. 
 
Mustoe, A.C.; Birnie, A.K.; Korgan, A.C.; Santo, J.B.; French, J.A. (2012) Natural 
variation in gestational cortisol is associated with patterns of growth in marmoset 
monkeys (Callithrix geoffroyi). Gen Comp Endocrinol. 175(3): 519-26). 
10.1016/j.ygcen.2011.12.020 
 
National Research Council Board on Agriculture (1985). Nutrient Requirements of Sheep, 
Sixth Revised Edition, 1985. Washington, DC: The National Academies Press. 
 
Newbern, D.; and Freemark, M. (2011). Placental hormones and the control of maternal 
metabolism and fetal growth. Current Opinion in Endocrinology, Diabetes, and Obesity. 
18(6): 409-16. 
 
Nørrelund, H. (2005). Consequences of Growth Hormone Deficiency for Intermediary 
Metabolism and Effects of Replacement. Growth Hormone Deficiency in Adults. Horm 
Res. Basel, Karger. 33 pp 103-120 doi:10.1159/000088419 
 
Novitskaya, T.; Baserga, M.; de Caestecker, M.P. (2011). Organ-specific defects in insulin-
like growth factor and insulin receptor signaling in late gestational asymmetric 
intrauterine growth restriction in cited1 mutant mice. Endocrinology. 152(6). 2503-2516. 
 
O'Connor, D.M.; Blache, D.; Hoggard, N.; Brookes, E.; Wooding, F.B.P.; Fowden, A.L.; 
Forhead, A.J. (2007). Developmental control of plasma leptin and adipose leptin 
messenger ribonucleic acid in the ovine fetus during late gestation: role of 
glucocorticoids and thyroid hormones. Endocrinology. 148: 3750–3757 
 
Ong, K.K; Ahmed, M.L.; Emmett, P.M.; Preece, M.A.; Dunger, D.B. (2000). Association 
between postnatal catch-up growth and obesity in childhood; prospective cohort study. 
British Medical Journey. 320(7240): 967-971. 
 
Phillips, D.I.; Fall, C.H.; Cooper, C.; Norman, R.J.; Robinson, J.S.; Owens, P.C. (1999). 
Size at birth and plasma leptin concentrations in adult life. International Journal of 
Obesity and Related Metabolic Disorders: Journal of the International Association for 
the Study of Obesity. 23(10): 1025-9. 
 
Rehfeldt, C., and Kuhn, G. (2006). Consequences of birth weight for postnatal growth 
performance and carcass quality in pigs as related to myogenesis. Journal of Animal 




Renaville, R.; Hammadi, M.; Portetelle, D. (2002) Role of the somatotropic axis in the 
mammalian metabolism, Domestic Animal Endocrinology, 23(1-2), 351-360, ISSN 0739-
7240, 10.1016/S0739-7240(02)00170-4. 
 
Rinderknecht, E. and Humbel, R.E. (1978). The amino acid sequence of human insulin-like 
growth factor 1 and its structural homology with proinsulin. The Journal of Biological 
Chemistry. 253(8): 2769-76.  
 
Rodriguez, T.A.; Sparrow, D.B.; Scott, A.N.; Withington, S.L.; Preis, J.I.; Michalicek, J.; 
Clements, M.; Tsang, T.E.; Shioda, T.; Beddington, R.S.; Dunwoodie, S.L. (2004). Cited 
1 is required in trophoblasts for placental development and for embryo growth and 
survival. Mol Cell Biol. 24(1) 228-44. 
 
Russel, A. (1984). Body condition scoring of sheep. In Pract. 6(3): 91-3. 
 
Sabin, M.A. (2011). "IGFBP-2 at the interface of growth and metabolism--implications for 
childhood obesity". Pediatric endocrinology reviews: PER (1565-4753), 8 (4), p. 382. 
 
Santos-Rosa, H.; Schneider, R.; Bannister, A.J.; Sherriff, J.; Bernstein, B.E.; Tolga Emre, 
N.C.; Schreiber, S.L.; Mellor, J.; Kouzarides, T. (2002). Active genes are tri-methylated 
at K4 of histone H3. Nature. 419: 407-11. 
 
Secchi, C., Borromeo, V., 1997. Structure and function of bovine growth hormone: 
bovinegrowth hormone as an experimental model for studies of protein-protein 
interactions. Journal of Chromatography B. 688:161-177. 
 
Setia, S., and Sridhar, M.G. (2009) Changes in GH/IGF-1 axis in intrauterine growth 
retardation: consequences of fetal programming? Hormone Metabolism Research; 
41(11):791–198. doi: 10.1055/s-0029-1231026. 
 
Shimasaki, S. and Ling, N. (1991). Identification and molecular characterization of insulin-
like growth factor binding proteins (IGFBP-1, -2, -3. -4, -5, -6). Prog Growth Factor Res. 
3(4); 243-66. 
 
Silha, J.V.; Yaoting, G.; Murphy, L.J. (2002). Impaired glucose homeostasis in insulinlike 
growth factor-binding protein-3-transgenic mice. Am J Phys Endo Met. 283 (5) E937-45. 
 
Sjögren, K.; Liu, J.L.; Blad, K.; Skrtic, S.; Vidal, O.; Wallenius, V.; LeRoith, D.; Törnell, 
J.; Isaksson, O.G.; Jansson, J.O.; Ohlsson, C. (1999). Liver-derived insulin-like growth 
factor I (IGF-1) is the principal source of IGF-1 in blood but is not required for postnatal 
body growth in mice. Proc Natl Acad Sci U.S.A. 96(12): 7088-92. 
 
Somwar, R.; Niu, W.; Kim, D.Y.; Sweeney, G.; Randhawa, V.K.; Huang, C.; Ramlal, T.; 
Klip, A. (2001). Differential effects of phosphatidylinositol 3-kinase inhibition on 
intracellular signals regulating GLUT4 translocation and glucose transport. The Journal 
of Biological Chemistry. 276(49): 46079-87). 
 78
 
Thorn, S.R.; Rozance, P.J.; Brown, L.D.; Hay, W.W. Jr. (2011). The Intrauterine Growth 
Restriction Phenotype: Fetal Adaptations and Potential Implications for Later Life Insulin 
Resistance and Diabetes. Seminars in Reproductive Medicine. 29(3): 225-236 doi: 
10.1055/s-0031-1275516. 
 
Tosh, D.N.; Fu, Q.; Callaway, C.W.; McKnight, R.A.; McMillen, I.C.; Ross, M.G.; Lane, 
R.H.; Desai, M. (2010). Epigenetics of programmed obesity: alteration in IUGR rat 
hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal 
catch-up growth. American Journal of Physiology. Gastrointestinal and Liver 
Physiology. 299(5). doi: 10.1152/ajpgi.00052.2010.  
 
Toste, F.P.; de Moura, E.G.; Lisboa, P.C.; Fagundes, A.T.; de Oliveira, E.; Passos, M.C.F. 
(2006). Neonatal leptin treatment programmes leptin hypothalamic resistance and 
intermediary metabolic parameters in adult rat. British Journal of Nutrition. 95: 830–837 
 
Tsuchiya, T.; Nago, Y.; Ozawa, A.; Matsumoto, M.; Sugahara, K.; Kubo, T.; Kato, H. 
(1998). Decrease of the obese gene expression in bovine subcutaneous adipose tissue by 
fasting. Bioscience, Biotechnology, and Biochemistry. 62: 2068-2069. 
 
Tuggle, C.K., Trenkle, A., 1996. Control of Growth Hormone Synthesis. Domestic 
Animal Endocrinology. 13: 1-33.  
 
Vaessen, N.; Heutink, P.; Janssen, J.A.; Witteman, J.C.; Testers, L.; Hofman, A.; Lamberts, 
S.W.; Oostra, B.A.; Pols, H.A.; van Duijn, C.M. (2001). Apolymorphism in the gene for 
IGF-1: functional properties and risk for type 2 diabetes and myocardial infarction. 
Diabetes. 50(3): 637-42. doi: 10.2337/diabetes.50.3.637 
 
Vehlo, G.; Hattersley, A.T.; Froguel, P.; (2000). Maternal diabetes alters birth weight in 
glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, 
insulin secretion or insulin sensitivity. Diabetologia. 43(8): 1060-3. 
 
Vickers, M.H.; Breier, B.H.; Cutfield, W.S.; Hofman, P.L.; Gluckman, P.D. (2000). Fetal 
origins of hyperphagia, obesity, and hypertension and postnatal amplification by 
hypercaloric nutrition. American Journal of Physiology. Endocrinology and Metabolism. 
279(1): E83-7. 
 
Vonnahme, K.A.; Hess, B.W.; Hansen, T.R.; McCormick, R.J.; Rule, D.C.; Moss, G.E.; 
Murdoch, W.J.; Nijland, M.J.; Skinner, D.C.; Nathanielsz; P.W.; Ford, S.P. (2003). 
Maternal undernutrition from early-to mid-gestation leads to growth retardation, cardiac 
ventricular hypertrophy, and increased liver weight in the fetal sheep. Biology of 







Vonnahme, K.A.; Luther, J.S.; Reynolds, L.P.; Hammer, C.J.; Carlson, D.B.; Redmer, 
D.A.; Caton, J.S. (2010). Impacts of maternal selenium and nutritional level on growth, 
adiposity, and glucose tolerance in female offspring in sheep. Domestic Animal 
Endocrinology. 39(4): 240-8. 
 
Wallace, J. M.; Aitken, R.P.; Cheyne, M.A. (1996). Nutrient partitioning and fetal growth 
in rapidly growing adolescent ewes. Journal of Reproduction and Fertiliy.107: 183-190.  
 
Wallace, J.M.; Aitken, R.P.; Milne, J.S.; Hay, W.W. Jr. (2004). Nutritionally mediated 
placental growth restriction in the growing adolescent: consequences for the fetus. 
Biology of Reproduction. 71(4). 1055-62. 
 
Wallace, J. M.; Bourke, D.A.; Aitken R.P.; Palmer, R.M.; Da Silva, P.; Cruickshank, M.A. 
(2000). Relationship between nutritionally-mediated placental growth restriction and fetal 
growth, body composition and endocrine status during late gestation in adolescent sheep. 
Placenta 21:100-8.  
 
Wallace, J. M.; Da Silva, P.; Aitken, R.P.; Cruickshank, M.A. (1997). Maternal endocrine 
status in relation to pregnancy outcome in rapidly growing adolescent sheep. Journal of 
Endocrinology 155: 359-68.  
 
Wheatcroft, S.B.; and Kearney, M.T. (2009). IGF-dependent and IGF-independent actions 
of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends 
Endocrinol Metab 20(4): 153-62. Doi:10.1016/j.tem.2009.01.002. 
 
Wojcik, J.; Postel-Vinay, M.C. (1995). Signal transduction of the growth hormone (GH) 
receptor, and GH-binding protein. Growth Hormone IGF Research Journal. 9: 51–5. 
 
Wu, G.; Bazer, F. W.; Wallace, J. M.; Spencer, T. E. (2006). BOARD-INVITED REVIEW: 
Intrauterine growth retardation: Implications for the animal sciences. Journal of Animal 
Science. 84:2316–2337 
 
Yakar, S.; Liu, J.L.; Stannard, B.; Butler, A.l Accili, D.; Sauer, B.; LeRoith, D. (1999). 
Normal growth and development in the absense of hepatic insulin-like growth factor 1. 
Proceedings of the National Academy of Sciences. 96(13): 7324-9. doi: 
10.1073/pnas.96.13.7324 
 
Yuan, Q.; Chen, L.; Liu, C.; Xu, K.; Mao, X.; Liu, C. (2011) Postnatal Pancreatic Islet β 
Cell Function and Insulin Sensitivity at Different Stages of Lifetime in Rats Born with 
Intrauterine Growth Retardation. PLoS ONE 6(10): e25167. 
doi:10.371/journal.pone.0025167 
 
Yura, S.; Itoh, H.; Sagawa, N.; Yamamoto, H.; Masuzaki, H.; Nakao, K.; Kawamura, M.; 
Kakui, K.; Ogawa, Y.; Fujii, S. (2005). Role of premature leptin surge in obesity 
resulting from intrauterine undernutrition. Cell Metabolism. 1(6): 371-8 
 80
 
Zapf, J.; Hauri, C.; Waldvogel, M.; Froesch, E.R. (1986). Acute metabolic effects and half-
lives of intravenously administered insulinlike growth factors I and II in normal and 
hypophysectomized rats. The Journal of Clinical Investigation. 77(6): 1768-75. 
 
De Zegher, F.; Francois, I.; van Helvoirt, M.; van den Berghe, G. (1997). Small as fetus and 
short as child: from endogenous to exogenous growth hormone. The Journal of Clinical 
Endocrinology and Metabolism. 82(7); 2021-26. 
 
Zhang, Y.; Proenca, R.; Maffei, M.; Barone, M.; Leopold, L.; Friedman, J.M. (1994). 
Positional cloning of the mouse obese gene and its human homologue. Nature. 
372(6505): 425-32. 
 
Zinn, S.A., Kazmer, G.W., Rycroft, H., Campbell, R.M., 1994. Growth hormone response 
after administration of growth hormone-releasing factor to proven diary sires. 
Livestock Production Science. 40:157-164. 
 
 
 
 
 
 
 
 
 
 
